BAJAJHCARE_06092024234920_BRSRBHL

Download as pdf or txt
Download as pdf or txt
You are on page 1of 45

Date: 6th September, 2024

BSE Limited National Stock Exchange of India Limited


Phiroze Jeejeebhoy Towers 5th Floor, Exchange Plaza,
Dalal Street Bandra Kurla Complex Bandra (East)
Mumbai – 400 001 Mumbai-400051

Scrip Code: 539872 Symbol : BAJAJHCARE

Sir/Madam,

Sub: Business Responsibility and Sustainability Report for the financial year 2023-24

Pursuant to Regulation 34(2)(f) of the SEBI (Listing Obligations & Disclosure Requirements)
Regulations 2015, please find enclosed the Business Responsibility and Sustainability Report (“BRSR”)
for the financial year 2023-24 which forms an integral part of the Annual Report for the financial year
2023-24.

The BRSR is also available on the website of the Company at www.bajajhealth.com

Kindly take the above on your record

Thanking you,

For and on behalf of Board of Directors


of Bajaj Healthcare Limited
Apurva Digitally signed
by Apurva
Bandiva Bandivadekar
Date: 2024.09.06
dekar 23:30:09 +05'30'

Apurva Bandivadekar
Company Secretary

BAJAJ HEALTHCARE LIMITED


Registered Office: 602-606, Bhoomi Velocity Infotech Park, Plot No: B-39, B-39A, B-39A/1, Road No. 23, Wagle Ind. Estate, Thane (West), Thane - 400604
Tel. : + 91 22 66177400/ 401; Fax : +91 22 66177458; E-mail : [email protected]
CIN No. L99999MH1993PLC072892
Bajaj Healthcare Limited

BUSINESS RESPONSIBILITY AND


SUSTAINABILITY REPORT
SECTION A: GENERAL DISCLOSURES
I. Details of the listed entity

1 Corporate Identity Number (CIN) of the Company L99999MH1993PLC072892


2 Name of the Listed Entity Bajaj Healthcare Limited (“BHCL”)
3 Year of Incorporation 1993
4 Registered Office address 602-606, Bhoomi Velocity Infotech Park, Plot No. B-39, B-39A, B-39
A/1, Rd No.23, Wagle Ind. Estate, Thane West Thane MH 400604
5 Corporate address 602-606, Bhoomi Velocity Infotech Park, Plot No. B-39, B-39A, B-39
A/1, Rd No.23, Wagle Ind. Estate, Thane West Thane MH 400604
6 E-mail ID [email protected]
7 Telephone +91 22 6617 7400
8 Website www.bajajhealth.com
9 Financial Year for which reporting is being done April 2023 – March 2024
10 Name of the Stock Exchange(s) where shares are listed a) National Stock Exchange of India Limited
b) BSE Limited
11 Paid-up Capital `13,79,92,000
12 Name and contact details (telephone, email address) of the Name- Mr. Sajankumar R. Bajaj
person who may be contacted in case of any queries on the
Designation- Chairman & Managing Director
BRSR Report
Email- [email protected]
Telephone- +91 22 6617 7400
13 Reporting boundary - Are the disclosures under this report made The disclosures under this report are made on Standalone
on a standalone basis (i.e., only for the entity) or on a consolidated Basis, unless otherwise specified elsewhere in the report.
basis (i.e., for the entity and all the entities which form a part of its
consolidated financial statements, taken together)
14 Name of assurance provider The Company will undertake the assurance of the BRSR in
the year of applicability.
15 Type of assurance obtained Not Applicable
II. Products/services
16. Details of business activities (accounting for 90% of the turnover):

S. No. Description of Main Activity Description of Business Activity % of Turnover of the entity
1 Manufacture of Pharmaceuticals Manufacturing & Sale of branded Pharmaceutical Products 100%
17. Products/Services sold by the entity (accounting for 90% of the entity’s Turnover):

S. No. Product/Service NIC Code % of Total Turnover contributed


1 Pharmaceutical Products 242 100%
III. Operations
18. Number of locations where plants and/or operations/offices of the entity are situated:

Location Number of Sites Number of offices Total


National 9 1 10
International - - -

64
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

19. Markets served by the entity:


a. Number of locations

Locations Number
National (No. of States) PAN India (28 States & 8 Union Territories)
International (No. of Countries) 62+
b. What is the contribution of exports as a percentage of the total turnover of the entity?
Currently, the Company exports its products to over 62 countries, contributing 24% to its overall turnover.
c. A brief on types of customers
The Company caters to a wide range of customers, including those in the pharmaceutical & nutraceutical industries.
Its customers primarily consist of healthcare professionals, patients, and companies that rely on high-quality Active
Pharmaceutical Ingredients (APIs) and formulations. The Company focuses on delivering value-added, cost-effective products
with reliable quality and quick lead times, earning the loyalty of both national and international clients​
IV. Employees
20. Details as at the end of Financial Year:
a. Employees and Workers (including differently abled):

S. No. Particulars Total (A) Male Female


No. (B) % (B / A) No. (C) % (C / A)
EMPLOYEES
1. Permanent (D) 873 810 93% 63 7%
2. Other than Permanent (E) 16 8 50% 8 50%
3. Total employees (D + E) 889 818 92% 71 8%
WORKERS
4. Permanent (F) 176 172 98% 4 2%
5. Other than Permanent (G) 505 483 96% 22 4%
6. Total workers (F + G) 681 655 96% 26 4%

b. Differently abled Employees and Workers:

S. No. Particulars Total (A) Male Female


No. (B) % (B / A) No. (C) % (C / A)
DIFFERENTLY ABLED EMPLOYEES
1. Permanent (D) 1 1 100% 0 0%
2. Other than Permanent (E) 0 0 0% 0 0%
3. Total differently abled employees (D + E) 1 1 100% 0 0%
DIFFERENTLY ABLED WORKERS
4. Permanent (F) 1 1 100% 0 0%
5. Other than permanent (G) 5 5 100% 0 0%
6. Total differently abled workers (F + G) 6 6 100% 0 0%

21. Participation/Inclusion/Representation of women:

Total (A) No. and percentage of Females


No. (B) % (B / A)
Board of Directors 10 2 25%
Key Management Personnel* 1 1 100%

*Key Management Personnel (KMP) includes the Company Secretary.

65
Bajaj Healthcare Limited

22. Turnover rate for permanent employees and workers: (Disclose trends for the past 3 years) –

FY 2023-24 FY 2022-23 FY 2021-22


(Turnover rate (Turnover rate (Turnover rate in the year
in current FY) in previous FY) prior to the previous FY)

Male Female Total Male Female Total Male Female Total

Permanent Employees 20% 39% 21% 7% 10% 7% 7% 9% 7%

Permanent Workers 8% 0% 8% 13% 0% 13% 9% 0% 9%

V. Holding, Subsidiary and Associate Companies (including joint ventures)


23. (a) Names of holding / subsidiary / associate companies / joint venture

S. No. Name of the holding/ Indicate whether % of Does the entity indicated at
subsidiary/ associate holding/ Subsidiary/ sharesheld column A, participate in the
companies/ joint Associate/ Joint by listed Business Responsibility initiatives
ventures (A) Venture entity of the listed entity? (Yes/No)

Nil Nil Nil Nil Nil

The Company has no Holding, Subsidiary, Joint Venture of Associate Company.

VI. CSR Details

24. (i) Whether CSR is applicable as per section 135 of Companies Act, 2013 – Yes

(ii) Turnover – `4,821,041,910

(iii) Net worth (in `) – `2,783,609,425

VII. Transparency and Disclosures Compliances

25. Complaints/Grievances on any of the principles (Principles 1 to 9) under the National Guidelines on Responsible
Business Conduct:

Stakeholder Grievance Redressal Mechanism FY 2023-24 FY 2022-23


group from in Place (Yes/No) (If yes, then (Current Financial Year) (Previous Financial Year)
whom provide web-link for grievance Number of Number of Remarks Number of Number of Remarks
complaint is redress policy) complaints complaints complaints complaints
received filed pending filed pending
during the resolution during the resolution
year at close of year at close of
the year the year
Communities Yes. Nil Nil Not Nil Nil Not
Applicable Applicable
The Company actively engages
with the community by carrying a
register during visits to peripheral
areas, allowing members to
submit written complaints
that are promptly addressed
by authorities. Additionally,
through CSR projects overseen
by a dedicated committee, the
Company collaborates with the
community, ensuring project
success and encouraging
feedback both in person and
via the “Contact Us” page on the
Company’s website - https://
www.bajajhealth.com/contact/

66
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

Stakeholder Grievance Redressal Mechanism FY 2023-24 FY 2022-23


group from in Place (Yes/No) (If yes, then (Current Financial Year) (Previous Financial Year)
whom provide web-link for grievance Number of Number of Remarks Number of Number of Remarks
complaint is redress policy) complaints complaints complaints complaints
received filed pending filed pending
during the resolution during the resolution
year at close of year at close of
the year the year
I n v e s t o r s Yes. Nil Nil Not Nil Nil Not
(other than Applicable Applicable
Investors and shareholders can easily
shareholders)
access dedicated contact information
on the Company’s website to address
Shareholders any concerns or inquiries they may Nil Nil Not Nil Nil Not
have - https://www.bajajhealth.com/ Applicable Applicable
grievance-redressal/
E m p l o y e e s Yes. Nil Nil Not Nil Nil Not
and workers Applicable Applicable
The Company has established a
comprehensive whistleblower
policy that ensures employees and
workers can confidentially report any
concerns about misconduct, ethical
violations, or other issues. This policy
provides multiple channels for raising
grievances, including email, an online
portal, and written complaints, to
ensure all concerns are addressed
promptly and effectively - https://
www.bajajhealth.com/wp-content/
uploads/2020/05/whistle-blower-
policy.pdf
Customers Yes. Nil Nil Not Nil Nil Not
Applicable Applicable
Customers can address their
grievances through multiple
communication channels,
including email, courier, and the
Quality Complaints & Enquiry Form
available on our website: http://
www.bajajhealth.com/contact/
Value Chain Yes. Nil Nil Not Nil Nil Not
Partners Applicable Applicable
The Company provides a
grievance mechanism for value
chain partners to raise concerns.
Complaints can be submitted via
email to bajajhealth@bajajhealth.
com. Additionally, value chain
partners can report issues through
the other contact details available
on the Company’s “Contact Us”
page - https://www.bajajhealth.
com/contact/
Other (please - - - - - - -
specify)
The Company is committed to addressing stakeholder concerns swiftly and effectively, ensuring clear and open communication
to meet their needs.

67
Bajaj Healthcare Limited

26. Overview of the entity’s material responsible business conduct issues


Please indicate material responsible business conduct and sustainability issues pertaining to environmental and social matters
that present a risk or an opportunity to your business, rationale for identifying the same, approach to adapt or mitigate the risk
along-with its financial implications, as per the following format

S. Material Indicate Rationale for identifying the In case of risk, approach Financial
No. issue whether risk / opportunity to adapt or mitigate implications
identified risk or of the risk or
opportunity opportunity
(R/O) (Indicate positive
or negative
implications)
1 Product Risk • Utilizing high-quality and As a Company in the Negative
Quality & safe pharmaceutical goods healthcare sector, it places
Safety ensures improved health the utmost importance on
outcomes. maintaining the highest
standards of product quality. To
• Compromising on product
mitigate risks associated with
quality directly impacts
any potential compromise in
patients overall health and
quality, it has implemented
well-being.
several key measures. The
• Any oversight in quality can Company has established
lead to product withdrawals, a robust system that allows
recalls, and regulatory stakeholders to efficiently
interventions. access and report adverse
events or product complaints.
• Quality lapses can result in
The Company is committed
reduced sales, reputational
to continuously monitoring
risks, and escalated litigation.
and managing the safety of all
• Such issues can ultimately the products throughout their
lead to increased litigation lifecycle, ensuring they meet
expenses for the company. the stringent quality standards.
Additionally, the dedicated
Quality Assurance teams
conduct regular audits to
ensure compliance with these
high-quality requirements,
reinforcing the commitment
to delivering safe and effective
products.
2 Innovation Opportunity • Qualified research scientists Not Applicable Positive
and R&D drive innovation, developing
differentiated, economical,
and eco-friendly products.
• Research centers are
Department of Science
and Industrial Research-
recognized and equipped
with the latest instruments.
• Expertise in creating
intellectual property assets by
developing non-infringing,
novel, cost-effective, and
environmentally friendly
processes for APIs, provides
a competitive edge in
innovation.

68
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

S. Material Indicate Rationale for identifying the In case of risk, approach Financial
No. issue whether risk / opportunity to adapt or mitigate implications
identified risk or of the risk or
opportunity opportunity
(R/O) (Indicate positive
or negative
implications)
3 Energy Opportunity • Energy efficiency reduces Not Applicable Positive
Conservation/ long-term operational
Efficiency costs and supports
decarbonization.
• Installed solar panels harness
renewable Energy, lowering
emissions.
• Continuous monitoring and
innovation help minimize
the carbon footprint and
align with sustainability
goals.
4 ESG Risk • ESG compliance risk arises The Company is committed Negative
Compliance & from non-adherence to to ensuring transparency and
Transparency regulatory standards in the accountability by aligning
pharmaceutical sector. with ESG guidelines and
regulations. It has established
• Non-compliance can
robust monitoring systems to
damage reputation, lead to
track ESG compliance across
legal issues, and resulting
all operations, ensuring that it
financial penalties.
meets the highest standards.
• Failure to meet standards Regular Quality Assurance
may negatively impact audits are conducted to
patient health, causing verify that the products
product recalls and consistently adhere to safety
regulatory actions coupled and quality requirements. It
with loss of reputation and also encourages stakeholders
impact the brand value. to report any adverse events
or product complaints,
fostering an open
environment for addressing
potential issues. By
adhering to ESG guidelines,
it safeguards health and
effectively minimizes
regulatory risks.

69
Bajaj Healthcare Limited

S. Material Indicate Rationale for identifying the In case of risk, approach Financial
No. issue whether risk / opportunity to adapt or mitigate implications
identified risk or of the risk or
opportunity opportunity
(R/O) (Indicate positive
or negative
implications)
5 Human Risk & Risk: To mitigate human capital- Negative & Positive
Capital Opportunity related risks, the Company
• The rate of employee
emphasizes the importance
turnover indicates how
of skill enhancement and
frequently employees leave
knowledge development
the organization, affecting
within its workforce. To this
stability and continuity.
end, it conducts a range of
• The terms of employee training programs, including
retention are crucial for sessions on soft skills, new
maintaining a skilled employee induction, ISO
workforce, with inadequate standards, problem-solving
strategies potentially leading using quality tools, human
to talent loss. rights considerations, work
ethics, environmental
• The costs of recruitment
awareness, fire safety
pose a financial risk,
protocols, and plastic
especially if high turnover
waste management. These
rates lead to frequent hiring
initiatives not only motivate
and onboarding expenses.
and engage employees but
Opportunity: also foster a workforce that
• Human capital is crucial is highly capable, efficient,
for business success and and prepared to tackle
employee engagement, operational challenges while
with a strong focus on ensuring compliance with
competence contributing to regulatory standards.
organizational growth.
• Skilled employees and
workers are valuable assets,
enhancing efficiency,
reducing time on tasks, and
minimizing injury risks.
• Offering a diverse and
needs-based range of
training courses, especially
in advanced fields like
digitalization, supports
employee development.
• Attracting and nurturing
the right talent ensures
their professional growth
and personal well-being
throughout their career with
the company.
• Providing specialized
programs designed for roles
requiring upgraded skills
helps in maintaining a skilled
and adaptable workforce.

70
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

S. Material Indicate Rationale for identifying the In case of risk, approach Financial
No. issue whether risk / opportunity to adapt or mitigate implications
identified risk or of the risk or
opportunity opportunity
(R/O) (Indicate positive
or negative
implications)
6 Corporate Risk • Loss of reputation due to To mitigate corporate Negative
Governance non-compliance or ethical governance risks, the
lapses. Company implements
several measures to ensure
• Incurring or levying of
regulatory compliance and
penalties from regulatory
effective management
breaches or governance
oversight. It regularly tracks
failures.
compliance with regulatory
• Ensuring satisfaction of requirements and reviews
both internal and external any new regulations that
stakeholders through may impact the operations.
effective governance Periodic assurance is
practices. provided to the Board, Audit
Committee, and Senior
• Long-term adverse direct or
Management to maintain
indirect environmental and
transparency and oversight.
social impacts resulting from
The policies are regularly
governance issues.
revised and updated, with
• Operating within the reviews conducted by
constraints of various laws the Board to ensure they
and regulations, exposing meet current standards.
the company to potential Additionally, it engages
legal risks. professionals and advisors to
evaluate risks associated with
contracts, assess the legal
responsibilities, and manage
liabilities. This approach helps
to adhere to contractual
obligations and mitigate
potential risks effectively.

71
Bajaj Healthcare Limited

S. Material Indicate Rationale for identifying the In case of risk, approach Financial
No. issue whether risk / opportunity to adapt or mitigate implications
identified risk or of the risk or
opportunity opportunity
(R/O) (Indicate positive
or negative
implications)
7 Climate Risk • Pose Physical risks such as To mitigate climate change Negative
Change floods, fires, heavy rains, etc. risks, the Company has
established a comprehensive
• Disruptions in supply chain
disaster management plan
• Pose Transitional risks like and installed effective
change in regulations, drainage systems to handle
compulsory adoption of unexpected rainfall and
renewable energy sources, temperature fluctuations.
etc. Additionally, it leverages
advanced technology to
combat climate change
by using energy-efficient
machinery and products.
Its commitment to
environmental sustainability
is further demonstrated
through our provision of
solar solutions, positioning
it as a forward-thinking,
customer-centric company
dedicated to green
initiatives and environmental
consciousness.
8 Community Opportunity • Strengthen relationships Not Applicable Positive
Relations with communities to
enhance perception among
stakeholders, customers,
employees, and investors.
• Support social causes to
foster customer loyalty and
demonstrate commitment.
• Maintain strong community
ties to mitigate reputational
and operational risks during
challenges.
• Engage with local
communities through
CSR projects, supporting
the Company’s enduring
presence and sustainable
practices.

72
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

S. Material Indicate Rationale for identifying the In case of risk, approach Financial
No. issue whether risk / opportunity to adapt or mitigate implications
identified risk or of the risk or
opportunity opportunity
(R/O) (Indicate positive
or negative
implications)
9 Stakeholder Risk • Loss of Reputation The Company has Negative
Engagement established a clear leadership
• Incurring or levying of
structure with well-defined
penalties
roles and responsibilities to
• Satisfaction of Internal & ensure effective sustainability
External Stakeholders management. It continuously
monitors and adheres to
• Long-term adverse direct or
regulatory requirements to
indirect impact
minimize non-compliance
• Legal & Financial Risks risks, conducts periodic
• Brand & Reputational Risk reviews to assess new
standards, and promptly
addresses emerging risks.
The Company’s policies
are regularly revised
and upgraded, with
comprehensive board
reviews to align with
evolving sustainability goals
and effectively manage
associated risks. Additionally,
a set process is in place to
engage with stakeholders
and incorporate their input,
while maintaining strong
stakeholder relationships
through a transparent
approach to business.

73
Bajaj Healthcare Limited

S. Material Indicate Rationale for identifying the In case of risk, approach Financial
No. issue whether risk / opportunity to adapt or mitigate implications
identified risk or of the risk or
opportunity opportunity
(R/O) (Indicate positive
or negative
implications)
10 Occupational Risk & Risk: To mitigate the risks of Negative & Positive
Health & Opportunity accidents and injuries
• Workplace accidents
Safety and ensure Occupational
and injuries can result in
Health and Safety (OHS), the
employee absenteeism,
Company has implemented
disrupting operations and
several key measures. Medical
causing delays in project
kits and first aid supplies
timelines.
are readily available at all
• Reduced productivity sites to provide immediate
may occur as a direct response in emergencies.
consequence of injuries, Additionally, on-site medical
impacting overall efficiency support is ensured through
and output. regular visits from a doctor
twice a week, addressing
• Increased healthcare costs
any medical needs promptly.
and potential legal liabilities
Comprehensive safety
can arise from workplace
manuals are accessible at
incidents, leading to higher
each plant, offering detailed
operational expenses.
guidelines and protocols
• Lower employee morale may to maintain a safe working
also develop as a result of environment. Regular
unsafe working conditions, health and safety training
potentially increasing sessions are conducted for
turnover rates and affecting all employees and workers,
workforce stability. focusing on safety practices,
Opportunity: emergency response
procedures, and proper use
• Implemented an of protective equipment.
Occupational Health Center. To further enhance safety,
• Established a system for routine safety audits and
prompt incident reporting inspections are carried out
to ensure timely resolution to identify potential hazards
and prevention of future and ensure compliance with
occurrences. safety standards. Emergency
response drills are scheduled
• Provided regular health and periodically to prepare
safety training to employees employees for various types
to enhance awareness and of incidents, and employee
ensure compliance with OHS feedback mechanisms are
standards. in place to report safety
concerns or suggestions,
fostering a proactive
approach to safety and
continuous improvement.

74
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

S. Material Indicate Rationale for identifying the In case of risk, approach Financial
No. issue whether risk / opportunity to adapt or mitigate implications
identified risk or of the risk or
opportunity opportunity
(R/O) (Indicate positive
or negative
implications)
11 Diversity and Opportunity • Unbiased hiring and growth Not Applicable Positive
Inclusion opportunities ensure merit-
based recruitment and
career advancement.
• Compliance with the internal
Equal Opportunity Policy
reinforces fair and equitable
treatment.
• Accessibility of office
premises supports inclusivity
for differently abled
individuals.
• CSR initiatives for
marginalized and vulnerable
groups contribute to social
equity and empowerment.

SECTION B: MANAGEMENT AND PROCESS DISCLOSURES


This section is aimed at helping businesses demonstrate the structures, policies and processes put in place towards adopting the NGRBC
Principles and Core Elements.

Disclosure Questions P1 P2 P3 P4 P5 P6 P7 P8 P9
Policy and management processes
1. a. Whether your entity’s policy/policies cover each Yes Yes Yes Yes Yes Yes Yes Yes Yes
principle and its core elements of the NGRBCs. (Yes/
The Company’s comprehensive suite of policies, including the
No)
Whistle-blower Policy, Code of Conduct, etc. fully integrates the
elements of the 9 principles outlined in the National Guidelines on
Responsible Business Conduct (NGRBC).
b. Has the policy been approved by the Board? (Yes/ Yes Yes Yes Yes Yes Yes Yes Yes Yes
No)
The Board of Directors, along with various functional committees/
senior management, has approved all statutory policies mandated
by SEBI’s Listing Obligations and Disclosure Requirements (LODR)
Regulations, 2015, as well as several additional voluntarily adopted
policies.
c. Web Link of the Policies, if available The Company’s policies are readily accessible on its website through
a designated web-link- https://www.bajajhealth.com/policies/
2. Whether the entity has translated the policy into Yes Yes Yes Yes Yes Yes Yes Yes Yes
procedures. (Yes / No)
3. Do the enlisted policies extend to your value chain Yes Yes Yes Yes Yes Yes Yes Yes Yes
partners? (Yes/No)
4. Name of the national and international codes/ The Company’s policies and guidelines align with the 9 Principles of
certifications/labels/ standards (e.g. Forest Stewardship the National Guidelines on Responsible Business Conduct (NGRBC)
Council, Fairtrade, Rainforest Alliance, and Trustee) and are recognized under various national and international
standards (e.g. SA 8000, OHSAS, ISO, BIS) adopted by standards.
your entity and mapped to each principle.

75
Bajaj Healthcare Limited

Disclosure Questions P1 P2 P3 P4 P5 P6 P7 P8 P9
The Company has achieved the following certifications:
i) ISO 9001:2015
ii) HACCP Certification
iii) Star-Kosher and OK Kosher Certification
iv) GMP Certification
v) Halal Certificate
vi) FSSAI License
vii) FSSC 22000
5. Specific commitments, goals and targets set by the Cultivate a Diverse and Inclusive Environment: Develop a
entity with defined timelines, if any. workplace culture that values diversity through inclusive hiring
practices and continuous employee development.
Adopt Sustainable Practices: Incorporate environmentally friendly
practices into operations by minimizing carbon emissions, leveraging
digital solutions, and supporting eco-conscious initiatives.
Support Employee Wellbeing: Boost employee satisfaction and
productivity with robust wellness programs, skill development
opportunities, mental health resources, career growth initiatives,
and efforts to promote a healthy work-life balance.
6. Performance of the entity against the specific The Company is actively working towards its goals and will track
commitments, goals and targets along-with reasons in progress as necessary.
case the same are not met.
Governance, leadership and oversight
7. Statement by director responsible for the business responsibility report, highlighting ESG related challenges, targets
and achievements (listed entity has flexibility regarding the placement of this disclosure)
As the Director responsible for the Business Responsibility Report of the Company, I am pleased to share our unwavering commitment
to Environmental, Social, and Governance (ESG) principles, which are integral to our business strategy and operations.
ESG Challenges:
In our journey towards sustainability, we face several challenges, including managing the environmental impacts of our operations,
ensuring the health and safety of our employees and workers, and maintaining robust governance practices across our value chain.
Adapting to the rapidly changing regulatory landscape and meeting the evolving expectations of our stakeholders also present
ongoing challenges. Additionally, the transition to more sustainable business practices requires continuous investment in new
technologies and processes, which can be resource-intensive.
ESG Targets:
To address these challenges, we have set ambitious targets that align with our long-term sustainability goals. We aim to achieve Zero
Liquid Discharge (ZLD) across all our manufacturing units, further reduce our greenhouse gas emissions, and continue to eliminate
hazardous waste landfilling in the foreseeable future. We are also focused on enhancing our energy efficiency through initiatives such
as the installation of solar panels, replacing old insulation to prevent heat loss, and transitioning to LED lighting across our facilities. On
the social front, we are committed to ensuring the well-being of our employees and workers by providing access to comprehensive
healthcare services, maintaining a safe and healthy work environment, and offering transition assistance programs.
ESG Achievements:
We are proud of the significant progress we have made in our ESG journey. Our Panoli unit has already achieved ZLD status, and we are
actively working to extend this achievement to other units. We have successfully implemented several projects to reduce our carbon
footprint, including the installation of solar panels, the replacement of mercury vapor lamps with LED lights, and the promotion
of indoor and outdoor plantation to improve air quality. Our commitment to waste management has resulted in the elimination
of hazardous waste landfilling and the responsible disposal of plastic, e-waste, and other hazardous materials in compliance with
regulatory standards.
In conclusion, while the path to sustainability is challenging, it is one we are committed to navigating with determination and
responsibility. We remain focused on achieving our ESG targets and continuously improving our practices to create long-term value
for our stakeholders and contribute to a more sustainable future.

76
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

Disclosure Questions P1 P2 P3 P4 P5 P6 P7 P8 P9
8. Details of the highest authority responsible for Mr. Anil C. Jain- Managing Director, holds the responsibility for
implementation and oversight of the Business overseeing sustainability issues and implementing Business
Responsibility policy (ies). Responsibility policies.
9. Does the entity have a specified Committee of the Mr. Sajankumar R. Bajaj- Chairman & Managing Director is the
Board/ Director responsible for decision making on responsible personnel for decision making on sustainability related
sustainability related issues? (Yes / No). If yes, provide aspects.
details.
10. Details of Review of NGRBCs by the Company:
Subject for Review Indicate whether review was Frequency (Annually/ Half
undertaken by Director / yearly/ Quarterly/ Any other
Committee of the Board/ Any – please specify)
other Committee
P P P P P P P P P P P P P P P P P P
1 2 3 4 5 6 7 8 9 1 2 3 4 5 6 7 8 9
Performance against above policies and follow up action The policies are regularly reviewed at set intervals or as required by
management. Additionally, annual evaluations are held during board
meetings to assess their effectiveness and offer recommendations
for any necessary adjustments or enhancements.
Compliance with statutory requirements of relevance to the The Company has established procedures to ensure full compliance
principles, and, rectification of any non-compliances with all applicable regulations.
11. Has the entity carried out independent assessment/ P P P P P P P P P P P P P P P P P P
evaluation of the working of its policies by an external 1 2 3 4 5 6 7 8 9 1 2 3 4 5 6 7 8 9
agency? (Yes/No). If yes, provide name of the agency.
No, the Company has not conducted any assessments by external
agencies. However, policies are reviewed internally as and when
needed.

12. If answer to question (1) above is “No” i.e. not all Principles are covered by a policy, reasons to be stated:

Questions P1 P2 P3 P4 P5 P6 P7 P8 P9
The entity does not consider the Principles material to its Not Applicable
business (Yes/No)
The entity is not at a stage where it is in a position to formulate
and implement the policies on specified principles (Yes/No)
The entity does not have the financial or/human and
technical resources available for the task (Yes/No)
It is planned to be done in the next financial year (Yes/No)
Any other reason (please specify)

SECTION C: PRINCIPLE WISE PERFORMANCE DISCLOSURE


This section is aimed at helping entities demonstrate their performance in integrating the Principles and Core Elements with key processes
and decisions. The information sought is categorized as “Essential” and “Leadership”. While the essential indicators are expected to be
disclosed by every entity that is mandated to file this report, the leadership indicators may be voluntarily disclosed by entities which aspire
to progress to a higher level in their quest to be socially, environmentally and ethically responsible.

77
Bajaj Healthcare Limited

PRINCIPLE 1 Businesses should conduct and govern themselves with integrity, and in a manner that is Ethical, Transparent
and Accountable.
ESSENTIAL INDICATORS
1. Percentage coverage by training and awareness programmes on any of the principles during the financial year:

Segment Total number Topics / principles covered under the training and its % age of persons in
of training impact respective category
and awareness covered by the
programmes held awareness programmes
Board of 2 The Company organized a comprehensive familiarization 100%
Directors program for its Board of Directors (BODs) and Key Managerial
Personnel (KMPs). This program encompassed a range of
Key Managerial 2 100%
topics, including:
Personnel
• Corporate Governance Practices
• Risk Management
• Cyber-security
• Work Ethics through the Code of Conduct
• Compliance and Regulatory Updates
• Innovation and R&D
• Human Rights, including the Prevention of Sexual
Harassment (POSH)
• Employee Well-being
• And, other relevant regulatory updates
Employees 4 Employees and workers receive various training and 40%
other than BoD awareness sessions, including induction training, leadership
and KMPs development, policy and compliance updates, and technical
Workers 3 skills enhancement. In line with the 9 NGRBC principles, 62%
additional training covers cyber-security, ethical conduct,
human rights, environmental sustainability, etc. These sessions
aim to ensure a well-rounded and compliant workforce.
2. Details of fines / penalties /punishment/ award/ compounding fees/ settlement amount paid in proceedings (by the
entity or by directors / KMPs) with regulators/ law enforcement agencies/ judicial institutions, in the financial year, in the
following format (Note: the entity shall make disclosures on the basis of materiality as specified in Regulation 30 of SEBI
(Listing Obligations and Disclosure Obligations) Regulations, 2015 and as disclosed on the entity’s website):

Monetary
NGRBC Name of regulatory/ enforcement Amount Brief of the Has an appeal been
Principle agencies/ judicial institutions (In INR) Case preferred? (Yes/No)
Penalty/Fine No major fines, penalties, etc. were imposed on the entity or its management during the FY
Settlement
Compounding Fee

Non-Monetary
NGRBC Name of regulatory/ enforcement Brief of the Has an appeal been preferred?
Principle agencies/ judicial institutions Case (Yes/No)
Imprisonment No imprisonment or punishment was imposed on the entity or its management during the FY
Punishment
3. Of the instances disclosed in Question 2 above, details of the Appeal/ Revision preferred in cases where monetary or non-
monetary action has been appealed.

Case Details Name of the regulatory/enforcement agencies/ judicial institutions


Not Applicable

78
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

4. Does the entity have an anti-corruption or anti-bribery policy? If yes, provide details in brief and if available, provide a
web-link to the policy.
Yes, the Company has established a comprehensive anti-bribery policy as part of its Code of Conduct, reflecting the Company’s
unwavering commitment to ethical business practices and adherence to all relevant anti-bribery laws.
The policy applies to all employees of the Company, including those who are permanent, temporary, or on contract, as well as those
working through contractors, retainers, or as full-time consultants. Additionally, it covers members of the Board of Directors. This broad
application ensures that every individual associated with the Company is held to the highest standards of integrity and ethical behavior.
The anti-bribery policy specifically prohibits the acceptance of gifts, presents, or gratuities of more than nominal value from suppliers
or customers. Such practices are viewed as serious breaches of discipline, as they can create conflicts of interest and potentially
compromise the Company’s interests. Employees and directors are expected to avoid any actions that could undermine the Company’s
reputation or integrity.
The policy also extends to the Company’s business partners, including suppliers, service providers, agents, and channel partners such
as dealers and distributors. These partners are required to adhere to the same principles of integrity and ethical conduct outlined in
the policy.
To ensure effective implementation and compliance, the Company conducts regular internal reviews and provides ongoing training to
all personnel. This proactive approach helps to reinforce the policy’s principles and address any potential issues promptly.
The Code of Conduct is accessible at https://www.bajajhealth.com/wp-content/uploads/2020/05/Code-of-Conduct.pdf.
5. Number of Directors/KMPs/employees/workers against whom disciplinary action was taken by any law enforcement
agency for the charges of bribery/ corruption:

FY 2023-24 FY 2022-23
(Current Financial Year) (Previous Financial Year)
Directors NIL NIL
KMPs NIL NIL
Employees NIL NIL
Workers NIL NIL

No disciplinary actions have been taken against Directors, Key Managerial Personnel (KMPs), employees, or workers by any law
enforcement agency related to bribery or corruption charges.
6. Details of complaints with regard to conflict of interest:

FY 2023-24 FY 2022-23
(Current Financial Year) (Previous Financial Year)

Number Remarks Number Remarks

Number of complaints received in relation to issues of NIL NIL NIL NIL


Conflict of Interest of the Directors

Number of complaints received in relation to issues of NIL NIL NIL NIL


Conflict of Interest of the KMPs

Complaints have not been received in regards to any instances of conflict of interest for Directors or KMPs during both the FY.
7. Provide details of any corrective action taken or underway on issues related to fines / penalties / action taken by
regulators/ law enforcement agencies/ judicial institutions, on cases of corruption and conflicts of interest.
During the FY, there have been no cases of corruption or conflicts of interest, and no fines or penalties have been imposed by regulatory
bodies, law enforcement agencies, or judicial institutions. As a result, no corrective actions were necessary.
8. Number of days of accounts payables ((Accounts payable *365) / Cost of goods/service procured) in the following format:

FY 2023-24 FY 2022-23
(Current Financial Year) (Previous Financial Year)

Number of days of accounts payables 128 81

79
Bajaj Healthcare Limited

9. Open-ness of business
Provide details of concentration of purchases and sales with trading houses, dealers, and related parties along-with loans and advances
& investments, with related parties, in the following format:

Parameter Metrics FY 2023-24 FY 2022-23


(Current Financial Year) (Previous Financial Year)
Concentration a. Purchases from trading houses as % of total Nil Nil
of Purchases purchases
b. Number of trading houses where purchases are Nil Nil
made from
c. Purchases from top 10 trading houses as % of Nil Nil
total purchases from trading houses
Concentration a. Sales to dealers / distributors to whom sales are Nil Nil
of Sales made
b. Number of dealers / distributors to whom sales Nil Nil
are made
c. Sales to top 10 dealers / distributors as % of Nil Nil
total sales to dealers / distributors
Share of RPTs a. Purchases (Purchases with related parties / Total Nil Nil
in Purchases)
b. Sales (Sales to related parties / Total Sales) Nil Nil
c. Loans & advances (Loans & advances given to Nil Nil
related parties / Total loans & advances)
d. Investments (Investments in related parties / Nil Nil
Total Investments made)

There have been no transactions of this nature made during the FY.

LEADERSHIP INDICATORS
1. Awareness programmes conducted for value chain partners on any of the principles during the financial year:

Total number of awareness Topics / principles covered %age of value chain partners covered (by value of business
programmes held under the training done with such partners) under the awareness programmes
Nil Nil Nil
During the FY, the Company did not conduct specific training sessions for its value chain partners. However, it is actively working to
integrate these partners into its sustainable practices as part of its broader environmental, social, and governance (ESG) initiatives.
Recognizing the vital role that suppliers play in its Business Responsibility and Sustainability agenda, the Company is developing ESG-
related awareness programs for its value chain partners. These future programs will focus on educating partners about ESG principles
and reporting, in alignment with the National Guidelines on Responsible Business Conduct (NGRBC). The Company aims to enhance
sustainable capacity building and improve transparency and accountability throughout its value chain.
2. Does the entity have processes in place to avoid/ manage conflict of interests involving members of the Board? (Yes/No)
If yes, provide details of the same.
Yes, the Company has implemented robust processes to manage conflicts of interest involving members of the Board. All directors,
senior management, and employees are required to uphold the highest standards of honesty and integrity, ensuring that their
personal interests do not interfere with their obligations to the Company. They are mandated to disclose any personal, financial, or
other interests that might create a conflict with the Company’s interests. Upon disclosure, the potential or actual conflict is reviewed
by higher management or an ethics committee, which assesses the nature and implications of the conflict. The review process involves
determining appropriate actions to address and mitigate the conflict, which may include measures such as recusal from specific
decisions or activities where the conflict arises. The Company continuously monitors and reassesses potential conflicts, providing
regular updates and training to ensure that all personnel are aware of their responsibilities and the procedures for managing conflicts.
These processes are designed to ensure transparency, uphold ethical standards, and protect the integrity of the Company’s decision-
making and operations.

80
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

PRINCIPLE 2 Businesses should provide goods and services in a manner that is sustainable and safe

ESSENTIAL INDICATORS
1. Percentage of R&D and capital expenditure (capex) investments in specific technologies to improve the environmental
and social impacts of product and processes to total R&D and capex investments made by the entity, respectively.

(Current Financial (Previous Financial Details of improvements in environmental and social impacts
Year) (FY 2023-24) Year) (FY 2022-23)
R&D - - Not Applicable
Capex - 3.39% During this FY, the Company did not make capital investments specifically
aimed at enhancing environmental and social impacts. However, in the
previous year, significant investments were made in a water treatment
plant and a multi-effect evaporator, reflecting its ongoing commitment
to environmental stewardship. The Company remains dedicated to
supporting environmental and social initiatives and will continue to
evaluate and invest in such projects whenever feasible and appropriate.
The Company’s commitment to these initiatives underscores its
dedication to sustainability and social responsibility.
2. a. Does the entity have procedures in place for sustainable sourcing? (Yes/No)
Yes, the Company has established comprehensive standard operating procedures (SOPs) for sustainable sourcing. These procedures
are designed to thoroughly assess and approve vendors, ensuring that the supplier network adheres to high sustainability standards.
The Company conducts regular evaluations of these procedures to maintain a dynamic and responsible supply chain.
The procurement strategy encompasses both local and international suppliers who meet the rigorous approval criteria. The
Company has a dedicated quality assurance team that continuously monitors and audits its vendors to ensure the consistent
quality of its products, with a particular focus on those providing essential components. This ongoing commitment to
sustainability is integral to its procurement process, reflecting its dedication to environmental and social responsibility.
b. If yes, what percentage of inputs were sourced sustainably?
The Company is working towards maximizing sustainable sourcing for all its purchases. Currently, specific percentages
of sustainably sourced inputs are not available, but we are committed to increasing this proportion as part of Company’s
sustainability goals.
3. Describe the processes in place to safely reclaim your products for reusing, recycling and disposing at the end of life, for:
(a) Plastics- The Company ensures that all plastic waste is collected and sent to authorised scrap dealers for proper disposal.
(b) E-waste- The Company complies with e-waste regulations by ensuring that all electronic waste is collected and disposed of
solely through authorized scrap collectors and vendors.
(c) Hazardous waste- Hazardous waste is collected, sent for recycling or co-processing through authorized third-party recyclers,
and disposed of in accordance with hazardous waste management regulations.
(d) Other waste- Other waste is managed and disposed of following the regulations and guidelines established by local regulatory
authorities.
4. Whether Extended Producer Responsibility (EPR) is applicable to the entity’s activities (Yes / No). If yes, whether the waste
collection plan is in line with the Extended Producer Responsibility (EPR) plan submitted to Pollution Control Boards? If
not, provide steps taken to address the same.
Yes, the Company responsibly manage post-consumer plastic waste by recovering an equivalent volume of plastic waste generated by
its products. This practice complies with Extended Producer Responsibility (EPR) standards. The action plan for EPR is carefully designed
to meet CPCB requirements, ensuring a structured approach to managing these responsibilities.

LEADERSHIP INDICATORS
1. Has the entity conducted Life Cycle Perspective / Assessments (LCA) for any of its products (for manufacturing industry)
or for its services (for service industry)? If yes, provide details in the following format?
NIC Name of % of total Boundary for which the Whether conducted by Results communicated in
Code Product Turnover Life Cycle Perspective / independent external public domain (Yes/No),
/Service contributed Assessment was conducted agency (Yes/No) If yes, provide the web-link.
Nil Nil Nil Nil Nil Nil
No Life Cycle Assessments were conducted during the FY for any of the products. However, the Company is planning to conduct the
same in the coming years for its core products.

81
Bajaj Healthcare Limited

2. If there are any significant social or environmental concerns and/or risks arising from production or disposal of your
products / services, as identified in the Life Cycle Perspective / Assessments (LCA) or through any other means, briefly
describe the same along-with action taken to mitigate the same.

Name of Product / Service Description of the risk / concern Action Taken

Not Applicable

3. Percentage of recycled or reused input material to total material (by value) used in production (for manufacturing
industry) or providing services (for service industry).

Indicate input material Recycled or re-used input material to total material

FY 2023-24 (Current Financial Year) FY 2022-23 (Previous Financial Year)

Nil Nil Nil

4. Of the products and packaging reclaimed at end of life of products, amount (in metric tonnes) reused, recycled, and
safely disposed, as per the following format:

FY 2023-24 (Current Financial Year) FY 2022-23 (Previous Financial Year)

Re-Used Recycled Safely Disposed Re-Used Recycled Safely Disposed

Plastics (including packaging) Nil Nil Nil Nil Nil Nil

E-waste Nil Nil Nil Nil Nil Nil

Hazardous waste Nil Nil Nil Nil Nil Nil

Other waste Nil Nil Nil Nil Nil Nil

5. Reclaimed products and their packaging materials (as percentage of products sold) for each product category.

Indicate product category Reclaimed products and their packaging materials


as % of total products sold in respective category

Nil Nil

PRINCIPLE 3 Businesses should respect and promote the well-being of all employees, including those in their value chains

ESSENTIAL INDICATORS
1. a. Details of measures for the well-being of employees:

Category % Of Employees covered by

Total Health Accident Maternity Paternity Day Care


(A) Insurance Insurance Benefits Benefits Facilities

Number % Number % Number % Number % Number %


(B) (B/A) (C) (C/A) (D) (D/A) (E) (E/A) (F) (F/A)

Permanent employees

Male 810 810 100% 810 100% 0 0% 0 0% 0 0%

Female 63 63 100% 63 100% 63 100% 0 0% 0 0%

Total 873 873 100% 873 100% 63 7% 0 0% 0 0%

Other than permanent employees

Male 8 8 100% 8 100% 0 0% 0 0% 0 0%

Female 8 8 100% 8 100% 8 100% 0 0% 0 0%

Total 16 16 100% 16 100% 8 50% 0 0% 0 0%

82
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

b. Details of measures for the well-being of workers:

Category % Of Workers covered by

Total Health Accident Maternity Paternity Day Care


(A) Insurance Insurance Benefits Benefits Facilities

Number % Number % Number % Number % Number %


(B) (B/A) (C) (C/A) (D) (D/A) (E) (E/A) (F) (F/A)

Permanent employees

Male 172 172 100% 172 100% 0 0% 0 0% 0 0%

Female 4 4 100% 4 100% 4 100% 0 0% 0 0%

Total 176 176 100% 176 100% 4 2% 0 0% 0 0%

Other than permanent workers

Male 483 483 100% 483 100% 0 0% 0 0% 0 0%

Female 22 22 100% 22 100% 22 100% 0 0% 0 0%

Total 505 505 100% 505 100% 22 4% 0 0% 0 0%

c. Spending on measures towards well-being of employees and workers (including permanent and other than
permanent) in the following format-

FY 2023-24 FY 2022-23
(Current Financial Year) (Previous Financial Year)

Cost incurred on well-being measures as a % of total revenue of the Company 0.30% 0.28%

The Company is committed to enhancing employees and workers well-being by prioritizing health and stress management
through various in-house initiatives, such as celebrating birthdays, festivals, and other engagement activities. The Company plans
to increase its investment in these engagement efforts to further support and improve employees & workers well-being.
2. Details of retirement benefits, for Current FY and Previous Financial Year.

Benefits FY 2023-24 (Current Financial Year) FY 2022-23Previous Financial Year


No. of No. of workers Deducted and No. of No. of workers Deducted and
employees covered as deposited employees covered as deposited
covered as a % of total with the covered as a % of total with the
a % of total workers authority a % of total workers authority
employees (Y/N/N.A.) employees (Y/N/N.A.)
PF 99.80% 100% Y 99.81% 100% Y
Gratuity 99.70% 100% Y 99.72% 100% Y
ESI 34.45% 28.55% Y 34.41% 32.73% Y
Others-Please Specify - - Not Applicable - - Not Applicable

3. Accessibility of workplaces
Are the premises / offices of the entity accessible to differently abled employees and workers, as per the requirements of the Rights of
Persons with Disabilities Act, 2016? If not, whether any steps are being taken by the entity in this regard.
The Company upholds a strong commitment to equality and inclusivity, which is integral to the workplace ethos. The facilities and
offices are designed to be fully accessible to employees and workers with disabilities, in compliance with the Rights of Persons with
Disabilities Act, 2016. It ensures that accessibility features, such as ramps, elevators, and other necessary adaptations, are integrated into
the design of the premises from the outset.
In addition to meeting the legal requirements, the Company continuously reviews and enhances the infrastructure to further support
the needs of employees with disabilities. This ongoing commitment reflects the dedication to creating an inclusive work environment
where all employees can thrive. The Company remains vigilant in making any necessary improvements to ensure that the facilities
remain fully accessible and supportive for everyone.

83
Bajaj Healthcare Limited

4. Does the entity have an equal opportunity policy as per the Rights of Persons with Disabilities Act, 2016? If so, provide a
web-link to the policy.
Yes, the Company upholds an equal opportunity policy that aligns with the requirements of the Rights of Persons with Disabilities Act,
2016. Its commitment to equal opportunity and non-discrimination is embedded in its Code of Conduct, which explicitly prohibits
discrimination in any aspect of employment. This includes recruiting, hiring, training, promotion, compensation, and other terms and
conditions of employment.
The Code of Conduct ensures that decisions are based solely on merit, qualifications, and job-related performance, rather than
on non-job-related characteristics such as race, color, ethnicity, gender, sexual orientation, age, religion, disability, veteran status,
or any other legally protected status. Discriminatory practices based on these characteristics are both against the policies and
illegal under the laws of many countries. The Company is committed to maintaining impartiality and ensuring that qualified
individuals are given the opportunity to advance within the organization. This dedication extends to adhering to all relevant
laws that ensure equal employment opportunities for all. This policy is designed to create a fair and inclusive work environment
where all employees and job applicants have equal access to opportunities and can contribute to the Company’s success
without facing discrimination.
The equal opportunity policy can be accessed at https://www.bajajhealth.com/wp-content/uploads/2020/05/Code-of-Conduct.pdf.
This document outlines the Company’s dedication to providing a workplace that is inclusive and equitable for all individuals, ensuring
that each person has the chance to reach their full potential.
5. Return to work and Retention rates of permanent employees and workers that took parental leave.

Gender Permanent employees Permanent workers

Return to Work rate Retention rate Return to Work rate Retention rate

Male Not Applicable Not Applicable Not Applicable Not Applicable

Female Nil Nil Nil Nil

Total Nil Nil Nil Nil

6. Is there a mechanism available to receive and redress grievances for the following categories of employees and worker?
If yes, give details of the mechanism in brief.

Yes/No (If yes, then give details of the mechanism in brief)

Permanent workers Yes, the Company has implemented comprehensive mechanisms to address and resolve
grievances for all employees and workers, ensuring a culture of transparency, equity,
and openness. Its approach is anchored in the Whistle-Blower Policy, which provides
a secure and confidential platform for employees and workers to report concerns about
unethical practices, misconduct, or violations of Company policies. This policy is designed
to encourage employees & workers to come forward without fear of retaliation, thereby
Other than Permanent workers
fostering a safe and accountable work environment. Employees & Workers can raise their
grievances directly to the Human Resources (HR) Manager or their immediate supervisors,
ensuring that issues are addressed promptly and effectively. For those who prefer to remain
anonymous, the Company has established a suggestion box located at the registered office,
allowing concerns to be reported without revealing the individual’s identity.
Permanent employees
When a grievance is received, it is meticulously reviewed and investigated by the HR team
or the designated Ombudsperson, ensuring that the process is fair and confidential. The
Ombudsperson or a designated Whistle Officer/Committee conducts a thorough examination
of the complaint, preserving evidence and determining appropriate actions based on the
investigation’s findings. The Company is committed to protecting individuals who report
Other than Permanent employees concerns from retaliation, discrimination, or any form of unfair treatment. The Whistle-
Blower Policy explicitly safeguards whistle-blowers, reinforcing Company’s commitment to
a respectful and fair workplace. Additionally, to maintain transparency and accountability,
it provides quarterly reports on the number of complaints received and their outcomes to
the Audit Committee and the Board. This systematic approach ensures that all grievances
are handled with the seriousness they deserve, aligning with the core values of integrity and
fairness.

84
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

7. Membership of employees and worker in association(s) or Unions recognised by the listed entity:

Category FY 2023-24 (Current Financial Year) FY 2022-23Previous Financial Year


Total No. of employees/ % (B/A) Total No. of employees/ %
employees/ workers in respective employees/ workers in respective (D/C)
workers in category, who are workers in category, who are part
respective part of association(s) respective of association(s) or
category (A) or Union (B) category I (C) Union (D)
Total Permanent employees 873 0 0% 1063 29 3%
-Male 810 0 0% 985 29 3%
-Female 63 0 0% 78 0 0%
Total Permanent workers 176 135 77% 110 110 100%
-Male 172 135 78% 110 110 100%
-Female 4 0 0% 0 0 0%

8. Details of training given to employees and workers:

Category FY 2023-24 (Current Financial Year) FY 2022-23 (Previous Financial Year)


Total On Health and On skills up Total On Health and On skills up
(A) Safety measures gradation (D) Safety measures gradation

No. (B) % (B/A) No. (C) % (C/A) No. (E) % (E/D) No. (F) % (F/D)

Employees
Male 810 810 100% 810 100% 985 985 100% 0 0%
Female 63 63 100% 63 100% 78 78 100% 0 0%
Total 873 873 100% 873 100% 1063 1063 100% 0 0%
Workers
Male 172 172 100% 172 100% 110 110 100% 0 0%
Female 4 4 100% 4 100% 0 0 0% 0 0%
Total 176 176 100% 176 100% 110 110 100% 0 0%
9. Details of performance and career development reviews of employees and worker:

Category FY 2023-24 (Current Financial Year) FY 2022-23Previous Financial Year


Total (A) No. (B) % (B/A) Total (C) No. (D) % (D/C)
Employees
Male 810 810 100% 985 985 100%
Female 63 63 100% 78 78 100%
Total 873 873 100% 1063 1063 100%
Workers
Male 172 172 100% 110 110 100%
Female 4 4 100% 0 0 0%
Total 176 176 100% 110 110 100%
10. Health and safety management system:
a. Whether an occupational health and safety management system has been implemented by the entity? (Yes/ No). If
yes, the coverage such system?
Yes, the Company has implemented a robust Occupational Health and Safety Management System (OHSMS) across all its
operations. This system is designed to prevent incidents proactively and ensure a safe working environment for all employees
and workers. The OHSMS is led by a Senior Officer who serves as the Chairman of the Safety Committee, while the Safety Manager
acts as the Secretary. The Safety Committee is comprised of representatives from key departments including Production,
Maintenance, Research & Development (R&D), Purchase, and Stores, along with an equal number of worker representatives
chosen by the employees themselves. This structure ensures a balanced approach to safety management with input from both
management and staff.

85
Bajaj Healthcare Limited

Training and awareness are critical components of the OHSMS. The Company conducts regular training sessions focused on
high-risk areas such as operating machinery and driving to enhance employees’ knowledge and promote safe work practices. The
Safety Committee meets quarterly to review safety practices, address issues, and support management in achieving the goals
outlined in the health and safety policy.
The system includes comprehensive safety measures, including regular safety surveys to identify and mitigate potential hazards. The
committee investigates all accidents, addresses complaints, and suggests corrective actions to prevent future occurrences. Additionally,
the Company is committed to ongoing education, training, and promotional activities to foster a culture of safety among all workers.
It handles any complaints related to imminent dangers or unsafe conditions promptly and implement corrective measures as
needed. The OHSMS is reviewed and updated every two years to ensure its effectiveness and alignment with best practices
and regulatory requirements. Overall, the Company’s OHSMS is structured to create a safe, health-conscious workplace through
proactive management, continuous improvement, and a strong focus on training and awareness.
b. What are the processes used to identify work-related hazards and assess risks on a routine and non-routine basis by
the entity?
The Company implements a comprehensive approach to identifying work-related hazards and assessing risks, both on a routine
and non-routine basis, as part of the Occupational Health and Safety Management System (OHSMS).
For routine hazard identification and risk assessment, it conducts regular inspections and audits of the occupational health
and safety management systems. These inspections are carried out systematically by the qualified safety officers, who use
detailed checklists and established protocols to evaluate the safety of the work environments and practices. Each unit within
the Company is equipped with an internal review mechanism designed to monitor performance and ensure compliance with
safety procedures. These internal reviews involve thorough evaluations of work processes, safety practices, and equipment to
identify any deviations from established safety norms. Regular internal audits are also scheduled to assess the effectiveness of
safety measures and identify areas requiring improvement. Additionally, it actively encourage employees and workers to report
potential hazards and unsafe conditions through various channels, including safety suggestion boxes and direct communication
with supervisors. Employees & Workers feedback is a vital component of the hazard identification process, as it provides valuable
insights into day-to-day operational risks that may not be immediately apparent through formal inspections.
For non-routine hazard identification and risk assessment, the Company employs Job Safety Analysis (JSA) for specific tasks that are
outside of routine operations or involve new activities. This analysis involves a detailed examination of the task to identify potential
hazards and implement control measures before the task is performed. Additionally, when introducing new processes, equipment,
or changes to existing operations, it conducts thorough risk assessments to evaluate potential hazards. This ensures that any new
or modified activity does not introduce new risks or compromise existing safety measures. The Company also continuously assess
risks related to emergency situations by conducting drills and simulations, which helps to identify potential gaps in the emergency
preparedness and response plans. These assessments allows to make necessary adjustments to effectively handle unforeseen events.
Overall, Company’s approach to hazard identification and risk assessment is dynamic and integrative, combining routine
inspections, internal reviews, employee feedback, and targeted risk assessments for non-routine activities. This systematic
approach ensures that it effectively manage and mitigate health and safety risks, thereby maintaining a safe and compliant
working environment for all employees and workers.
c. Whether you have processes for workers to report the work-related hazards and to remove themselves from such
risks. (Y/N)
Yes, the Company has established comprehensive processes for workers to report work-related hazards and to remove themselves
from such risks. Each of the sites is equipped with clearly defined incident and hazard reporting procedures. These procedures are
designed to enable workers to promptly identify and report unsafe working conditions or potential hazards.
Workers are provided with accessible channels to report these hazards, which include direct communication with supervisors,
designated safety officers, and a formal reporting system that may include online platforms or physical suggestion boxes. Once
a hazard is reported, the Company takes immediate action to assess and address the risk, ensuring that necessary corrective
measures are implemented swiftly.
Additionally, the procedures include provisions for workers to remove themselves from hazardous situations without fear
of retaliation. Workers are encouraged to prioritize their safety and can take appropriate action to distance themselves from
immediate risks. This system ensures that workers can work in an environment where their safety is actively protected and where
they are supported in reporting and addressing potential hazards.
d. Do the employees/ worker of the entity have access to non-occupational medical and healthcare services? (Yes/ No)
Yes, employees and workers have access to non-occupational medical and healthcare services. The Company ensures that the
workforce can avail themselves of a range of healthcare services that address medical needs beyond occupational health. This
includes access to general medical care, specialist consultations, and wellness programs.

86
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

The comprehensive healthcare benefits extend to routine medical check-ups, preventive care, and treatment for various
health conditions that are not work-related. This approach reflects the commitment to the overall well-being of the workforce,
supporting their health both within and outside the workplace. The Company aims to provide a supportive environment where
the workforce has the necessary resources to maintain their health and well-being effectively.
11. Details of safety related incidents, in the following format:

Safety Incident/Number Category FY 2023-24 FY 2022-23


(Current Financial Year) (Previous Financial Year)

Lost Time Injury Frequency Rate (LTIFR) (per Employees 0 0


one million-person hours worked) Workers 0 0
Total recordable work-related injuries Employees 0 0
Workers 0 0
No. of fatalities Employees 0 0
Workers 0 0
High consequence work-related injury or ill- Employees 0 0
health (excluding fatalities) Workers 0 0
12. Describe the measures taken by the entity to ensure a safe and healthy work place.
The health and safety of Company’s employees and workers are paramount. To ensure a safe and healthy workplace, the Company has
implemented a comprehensive suite of measures, reflecting the commitment to fostering a robust safety culture across all the sites
and locations.
The Company’s approach to health and safety is built on a shared responsibility model, engaging employees and workers at all levels
to promote and uphold safety standards. It actively works to reduce reportable incidents and minimize injuries by continuously
monitoring and improving safety performance.
Key measures include:
1. Hospital Tie-Ups: The Company has established partnerships with local hospitals to provide immediate medical care and
support when needed.
2. Medical Kits and First Aid: The facilities are equipped with well-stocked medical kits and first aid supplies to address minor
injuries and emergencies promptly.
3. Occupational Health Center: An on-site Occupational Health (OH) center is available to manage health-related concerns,
conduct regular health checks, and provide specialized care.
4. Medical Visits: The Company arranges for a doctor to visit the sites twice a week to offer medical consultations and address
health issues proactively.
5. Nurse Availability: A qualified nurse is available during general shifts to provide medical assistance and ensure immediate
response to health concerns.
6. Ambulance Services: An ambulance, staffed with trained drivers, is on standby to handle medical emergencies and transport
employees or workers to medical facilities if required.
7. Mock Drills: Mock drills are conducted to prepare the workforce for emergency situations and ensure readiness in case of an incident.
8. Training Programs: A structured training schedule is followed to educate employees and workers on safety protocols,
emergency response, and best practices for maintaining a safe work environment.
By integrating these measures into the operations, the Company aims to create a work environment that prioritizes health and
safety, ensuring that the employees and workers are well-protected and supported in their daily activities.
13. Number of Complaints on the following made by employees and workers:

FY 2023-24 (Current Financial Year) FY 2022-23 (Previous Financial Year)


Filed during Pending Remarks Filed during Pending Remarks
the year resolution at the year resolution at
the end of year the end of year
Working Conditions Nil Nil Not Applicable Nil Nil Not Applicable
Health & Safety Nil Nil Not Applicable Nil Nil Not Applicable

87
Bajaj Healthcare Limited

14. Assessments for the year:

% of your plants and offices that were assessed (by entity or statutory authorities or third parties)
Health & Safety practices 100%
Working Conditions 100%

15. Provide details of any corrective action taken or underway to address safety-related incidents (if any) and on significant
risks / concerns arising from assessments of health & safety practices and working conditions.
No significant risks or concerns were identified in the assessment during the FY.

LEADERSHIP INDICATORS
1. Does the entity extend any life insurance or any compensatory package in the event of death of (A) Employees (Y/N) (B)
Workers (Y/N)
Yes, the Company provides comprehensive life insurance and compensatory packages for both employees and workers. It has
implemented a Group Accidental Policy, a Term Plan, and a Workmen Compensation Policy to ensure that in the unfortunate event of
a death, financial support is extended to the affected family. This commitment underscores the dedication to the welfare and security
of the workforce.
2. Provide the measures undertaken by the entity to ensure that statutory dues have been deducted and deposited by the
value chain partners.
To ensure that statutory dues are correctly deducted and deposited by the value chain partners, the Company enforces strict adherence
to applicable regulations. It meticulously reviews these activities during both internal and statutory audits. Furthermore, it holds the
value chain partners to high standards of business responsibility, emphasizing the importance of transparency and accountability in
all transactions.
3. Provide the number of employees / workers having suffered high consequence work-related injury / ill-health / fatalities
(as reported in Q11 of Essential Indicators above), who have been are rehabilitated and placed in suitable employment
or whose family members have been placed in suitable employment:

Total no. of affected employees/ workers No. of employees/workers that are rehabilitated
and placed in suitable employment or whose family
members have been placed in suitable employment

FY 2023-24 (Current FY 2022-23 FY 2023-24 FY 2022-23


Financial Year) (Previous Financial Year) (Current Financial Year) (Previous Financial Year)

Employees Nil Nil Nil Nil

Workers Nil Nil Nil Nil

4. Does the entity provide transition assistance programs to facilitate continued employability and the management of
career endings resulting from retirement or termination of employment? (Yes/ No)
Yes, the Company provides transition assistance programs to support the employees in managing career transitions due to retirement
or termination of employment. These programs are designed to ensure continued employability and to help the employees navigate
the changes that come with the end of their tenure with the Company. Through these initiatives, it aims to offer guidance, resources,
and support to help them prepare for the next steps in their careers or retirement, fostering a smooth and positive transition.
5. Details on assessment of value chain partners:

% of value chain partners (by value of business done with such partners) that were assessed
Health & Safety practices Refer Note Below
Working Conditions Refer Note Below
In line with the Company’s policy, it has identified primary vendors who provide more than 50% of the raw materials for a specific
product. It conduct thorough evaluations for each of these critical vendors, addressing aspects such as environmental impact, health
and safety standards, labor practices, data privacy, and crisis management.
6. Provide details of any corrective actions taken or underway to address significant risks / concerns arising from assessments
of health and safety practices and working conditions of value chain partners.
No significant risks or concerns were identified in the assessment during the FY.

88
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

PRINCIPLE 4 Businesses should respect the interests of and be responsive to all its stakeholders

ESSENTIAL INDICATORS
1. Describe the processes for identifying key stakeholder groups of the entity.
The Company employs a thorough and structured approach to identify and engage with key stakeholder groups, acknowledging
their essential role in managing social risks and fostering positive relationships. The process starts with a comprehensive mapping
of all individuals, groups, and institutions that have a significant impact on or are affected by business operations. This stakeholder
mapping includes a wide range of entities: employees, shareholders, investors, suppliers, customers, channel partners, regulators,
lenders, research analysts, local and broader communities, and non-governmental organizations (NGOs).
To effectively address and resolve concerns from these stakeholders, the Company has established a robust grievance redressal
mechanism. This mechanism facilitates regular communication through various channels, such as consultations, surveys, and feedback
forms, to capture and understand stakeholder perspectives and expectations. By actively engaging with these groups and responding
to their feedback, we ensure that their needs and concerns are addressed in a timely and effective manner. This proactive engagement
not only helps in managing social risks but also strengthens the relationships with stakeholders. It reinforces Company’s commitment
to aligning the business practices with their interests, thereby building trust and ensuring that the Company’s operations are responsive
to their expectations and needs.
2. List stakeholder groups identified as key for your entity and the frequency of engagement with each stakeholder group.

Stakeholder Whether Channels of communication Frequency of Purpose and scope of


Group identified as (Email, SMS, Newspaper, engagement engagement including key
Vulnerable & Pamphlets, Advertisement, (Annually/ Half yearly/ topics and concerns raised
Marginalized Community Meetings, Notice Quarterly / others – during such engagement
Group (Yes/No) Board, Website), Other please specify)
Shareholders & No • Media Announcements & Quarterly, Half-yearly, Company’s financial and
Investors Published Results Annually & Event Based non-financial performance,
conference calls, shareholder
• Annual General Meetings
and investor expectations and
• Stock Exchanges (SE) complaints, market growth,
Intimations discussion on business
outlook, and other relevant
• Emails
factors.
• Annual Reports
• Company Website
• Shareholders/Board Meetings
• Investor Meets/ Presentations
Customers No • Company Website Event Based Introduction of New Products,
Marketing & Publicity,
• Branding & Promotions
Information about products
• Social Media Applications and services, Product
Availability, Product Quality,
• Advertisements
Product Pricing, Grievances
• Brand Campaigns and Feedbacks, Safety
• Sales Promotions Awareness & safe usage, etc.

• Customer plant visits


• Telephone
• Emails & Enquiry Forms
• Customer Surveys

89
Bajaj Healthcare Limited

Stakeholder Whether Channels of communication Frequency of Purpose and scope of


Group identified as (Email, SMS, Newspaper, engagement engagement including key
Vulnerable & Pamphlets, Advertisement, (Annually/ Half yearly/ topics and concerns raised
Marginalized Community Meetings, Notice Quarterly / others – during such engagement
Group (Yes/No) Board, Website), Other please specify)
Employees and No • Email On regular basis Performance Review, Benefits
Workers Structure, On-Job Trainings,
• Interactive Meetings
Career Development and
• Webinar & Training Programmes Growth Opportunities, Skills
upgradation programmes,
• Conferences
Fire Drills, Policies, Advances
• Newsletter & Reports in Company, etc.
• One-on-One Interactions
• Cultural Activities
• Notice Board & Online Portals
• Employee Surveys
Suppliers & Yes • Emails Periodically Material Deliveries, Timely
Vendors Payments, MSMED Act,
• Vendor Checks
Material Quality, Raising
• Contracts/Agreements Grievances, etc.
Government No • Reporting/Filings On Periodical basis as Policy & Regulatory
provided under relevant matters, Filing of Returns,
and Regulatory • Submissions/Applications
legislations Amendments & Approvals,
Bodies • Emails Assessments Results, Tax
Payments, Inspections, Grant
• Company Website
and maintenance of licenses
to manufacture and market
Company’s products, etc.
Communities & Yes • Community Meetings Periodically CSR Initiatives, Social Impact
NGO Programmes, Grievances and
• Community Visits & Projects
Complaints Management, etc.
• Campaigns
• Company Website
• Partnership with Local Charities

LEADERSHIP INDICATORS
1. Provide the processes for consultation between stakeholders and the Board on economic, environmental, and social
topics or if consultation is delegated, how is feedback from such consultations provided to the Board.
The Company utilizes a structured approach to consult stakeholders on economic, environmental, and social matters through the
Stakeholders’ Relationship Committee. This Committee is established in line with Regulation 20 of the Listing Regulations and Section
178 of the Companies Act. Its primary role involves addressing and resolving shareholder and investor concerns, such as issues related
to dividends, annual reports, share transfers, and other shareholder services. The Committee also oversees share transfer processes and
ensures that effective voting rights are facilitated for shareholders.
Feedback from stakeholders is managed through a comprehensive communication process. Departmental heads engage regularly
with both internal and external stakeholders, and these insights are shared with senior management. Senior management then reports
to the Board, ensuring that stakeholder concerns are integrated into strategic decision-making. The CSR Committee also plays a crucial
role by maintaining regular contact with local communities to address their concerns and issues effectively.
For shareholders and investors, the Company provides a dedicated communication channel at [email protected]. This allows
for direct submission of queries and feedback. All received feedback is documented, reviewed, and addressed by the relevant teams,
with summaries and actions reported to the Board. This systematic approach ensures that stakeholder feedback is considered in
decision-making processes and that necessary actions are taken to address concerns effectively.

90
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

2. Whether stakeholder consultation is used to support the identification and management of environmental, and social
topics (Yes / No). If so, provide details of instances as to how the inputs received from stakeholders on these topics were
incorporated into policies and activities of the entity.
Yes, stakeholder consultation plays a vital role in identifying and managing environmental and social topics. The Company actively
engages with both internal and external stakeholders to gather insights on key issues affecting our operations. This engagement helps
it to prioritize and address sustainability challenges that are most relevant to its business.
Feedback from these consultations is directly incorporated into its policies and activities. By aligning the strategies with stakeholder
concerns, we set ambitious sustainability targets and effectively address material issues. This ensures the environmental and social
policies are responsive and well-informed, enhancing Company’s commitment to sustainable practices.
3. Provide details of instances of engagement with, and actions taken to, address the concerns of vulnerable/ marginalized
stakeholder groups.
The Company is committed to engaging with and addressing the concerns of vulnerable and marginalized stakeholder groups
through targeted initiatives. It recognizes the importance of understanding and responding to the needs of these groups, especially
in the areas surrounding its operations.
The Company’s efforts include several initiatives aimed at improving the quality of life for marginalized communities. In the area
of Community Health Care, it has implemented health camps and provided medical assistance to underserved populations. For
Sanitation and Hygiene, it has supported the development of infrastructure and awareness programs to enhance living conditions.
Additionally, its focus on Education and Knowledge Enhancement includes providing educational resources and support to local
schools and learning centers.
These initiatives reflect its dedication to addressing the specific needs of vulnerable groups and ensuring that their concerns are
effectively managed through the CSR programs and community engagement efforts.

PRINCIPLE 5 Businesses should respect and promote human rights

ESSENTIAL INDICATORS
1. Employees and workers who have been provided training on human rights issues and policy(ies) of the entity, in the
following format:

Category FY 2023-24 (Current Financial Year) FY 2022-23 (Previous Financial Year)


Total No. of employees / % (B/A) Total (C) No. of employees / % (D/C)
(A) workers covered (B) workers covered (D)
Employees
Permanent 873 873 100% 1063 1063 100%
Other than permanent 16 16 100% 68 68 100%
Total Employees 889 889 100% 1131 1131 100%
Workers
Permanent 176 176 100% 110 110 100%
Other than permanent 505 505 100% 775 775 100%
Total Workers 681 681 100% 885 885 100%

2. Details of minimum wages paid to employees and workers, in the following format:

Category FY 2023-24 (Current Financial Year) FY 2022-23 (Previous Financial Year)


Total Equal to Minimum More than Total Equal to Minimum More than
(A) Wage Minimum Wage (D) Wage Minimum Wage

No. (B) % (B/A) No. (C) % (C/A) No. (E) % (E/D) No. (F) % (F/D)

Employees
Permanent
Male 810 0 0% 810 100% 985 323 33% 662 67%
Female 63 0 0% 63 100% 78 32 41% 46 59%

91
Bajaj Healthcare Limited

Category FY 2023-24 (Current Financial Year) FY 2022-23 (Previous Financial Year)


Total Equal to Minimum More than Total Equal to Minimum More than
(A) Wage Minimum Wage (D) Wage Minimum Wage

No. (B) % (B/A) No. (C) % (C/A) No. (E) % (E/D) No. (F) % (F/D)

Other than permanent


Male 8 0 0% 8 100% 58 18 31% 40 69%
Female 8 0 0% 8 100% 10 3 30% 7 70%
Workers
Permanent
Male 172 0 0% 172 100% 110 0 0% 110 100%
Female 4 0 0% 4 100% 0 0 0% 0 0%
Other than permanent
Male 483 0 0% 483 100% 775 125 16% 650 84%
Female 22 0 0% 22 100% 0 0 0% 0 0%
3. Details of remuneration/salary/wages
a. Median remuneration / wages:

Male Female
Number Median remuneration/ salary/ Number Median remuneration/ salary/
wages of respective category wages of respective category
Board of Directors (BoD) - 5 `33,80,576 1 `10,83,241
excludes Independent Directors
Key Managerial Personnel* 1 `9,50,126 1 `50,524
Employees other than BoD and 935 `2,02,091 109 `1,84,228
KMP
Workers 355 `2,38,626 7 `4,32,083

*The only Key Managerial Personnel (KMP) identified is the Company Secretary. Until January 2024, the Company Secretary was
male. Following his resignation, the Company Secretary role has been filled by a female starting February 2024. Therefore, the
median salary has been calculated for both male and female positions.
b. Gross wages paid to female as % of total wages paid by the entity, in the following format:

FY 2023-24 (Current Financial Year) FY 2022-23 (Previous Financial Year)


Gross wages paid to female as % of 7.18% 7.14%
total wages
4. Do you have a focal point (Individual/ Committee) responsible for addressing human rights impacts or issues caused or
contributed to by the business? (Yes/No)
Yes, the Company has a dedicated focal point for addressing human rights impacts and issues. Mr. Anil Jain, the Joint Managing
Director, is specifically responsible for overseeing and managing human rights-related aspects of the operations. His role includes
ensuring that the practices are in full compliance with human rights standards and addressing any issues that may arise. He works
closely with various departments to integrate human rights considerations into the corporate policies and operational procedures.
The Company’s commitment to human rights is underpinned by its “Whistle-Blower Policy,” which is a key element of its broader ethical
framework. This policy establishes a confidential reporting mechanism for stakeholders to raise concerns about unethical behavior,
suspected fraud, or violations of the code of conduct. It provides a structured process for investigating these concerns and taking
corrective actions when necessary. This approach helps to identify and resolve human rights issues promptly, ensuring that the workplace
remains free from discrimination, harassment, and other unethical practices. Through Mr. Jain’s leadership and Company’s robust reporting
mechanisms, it is dedicated to maintaining the highest standards of integrity and respect for human rights in all its business activities.
5. Describe the internal mechanisms in place to redress grievances related to human rights issues.
The Company has established comprehensive internal mechanisms to address grievances related to human rights issues. It operates
an open-door policy, allowing employees and workers to directly present their concerns to their Head of Department or the HR Head.
This approach ensures that grievances are promptly communicated and addressed at the management level.

92
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

For more formal or sensitive issues, the Whistle Blower Policy provides a confidential channel for reporting concerns, including human
rights violations. Additionally, the Prohibition of Sexual Harassment at Workplace policy is in place to address any instances of sexual
harassment, reinforcing Company’s commitment to a safe and respectful work environment. These mechanisms collectively ensure
that human rights grievances are managed with the utmost seriousness and integrity.
6. Number of Complaints on the following made by employees and workers:

FY 2023-24 FY 2022-23
(Current Financial Year) (Previous Financial Year)
Filed Pending resolution Remarks Filed Pending Remarks
during at the end of year during resolution at
the year the year the end of year
Sexual Harassment Nil Nil Not Applicable Nil Nil Not Applicable
Discrimination at workplace Nil Nil Not Applicable Nil Nil Not Applicable
Child Labour Nil Nil Not Applicable Nil Nil Not Applicable
Forced Labour/ Involuntary Labour Nil Nil Not Applicable Nil Nil Not Applicable
Wages Nil Nil Not Applicable Nil Nil Not Applicable
Other human rights related issues Nil Nil Not Applicable Nil Nil Not Applicable

During the FY, there were no complaint received on any of the human rights related aspects.
7. Complaints file under the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013,
in the following format:

FY 2023-24 FY 2022-23
(Current Financial (Previous Financial Year)
Year)
Total Complaints reported under Sexual Harassment on of Women at Nil Nil
Workplace (Prevention, Prohibition and Redressal) Act, 2013 (POSH)
Complaints on POSH as a % of female employees / workers Nil Nil
Complaints on POSH upheld Nil Nil
During the FY, there were no complaint received on POSH from any of the female employee/worker.
8. Mechanisms to prevent adverse consequences to the complainant in discrimination and harassment cases.
The Company has established robust mechanisms to prevent adverse consequences for complainants in cases of discrimination and
harassment, aligned with its Whistle Blower Policy. This policy is designed to foster a safe environment for employees to report any
unethical behavior, including discrimination and harassment, without fear of retaliation. The Company’s approach ensures that all
complaints are addressed fairly and confidentially, reinforcing its commitment to maintaining high standards of integrity and respect
in the workplace.
To prevent any adverse outcomes for the complainant, the policy guarantees that no unfair treatment will be meted out to individuals
who raise concerns. This includes protection against retaliation, such as threats, intimidation, demotion, or any other discriminatory
actions. The Whistle Blower Policy provides a secure framework for reporting issues, and any retaliatory actions are treated with utmost
seriousness, including potential disciplinary measures. The confidentiality of the complainant is maintained throughout the process to
safeguard their privacy and encourage open reporting.
Furthermore, the Company ensures that all individuals involved in handling complaints adhere to strict confidentiality protocols. The
process for addressing grievances includes regular oversight, with quarterly reports on the number and outcomes of complaints
being reviewed by the Audit Committee and the Board. This continuous monitoring helps to uphold the integrity of the grievance
redressal mechanisms and ensures that the protective measures are effective and robust, fostering a work environment free from fear
of retaliation or victimization.
9. Do human rights requirements form part of your business agreements and contracts? (Yes/No)
Yes, human rights requirements do form part of the business agreements and contracts where relevant. In line with the Company’s
commitment to uphold high standards of ethical conduct and integrity, it incorporates specific clauses related to human rights into its
agreements with partners, suppliers, and other stakeholders. These clauses ensure that all parties involved adhere to principles of fairness,
non-discrimination, and respect for fundamental human rights. By embedding these requirements into its contractual obligations, it
reinforce its dedication to ethical practices and the protection of human rights throughout the business operations and relationships.

93
Bajaj Healthcare Limited

10. Assessments for the year:

% of your plants and offices that were assessed


(by entity or statutory authorities or third parties)
Child labour 100%
Forced/involuntary labour 100%
Sexual harassment 100%
Discrimination at workplace 100%
Wages 100%
Others – please specify -
11. Provide details of any corrective actions taken or underway to address significant risks / concerns arising from the
assessments at Question 10 above.
No significant risks or concerns were identified in the assessment during the FY.

LEADERSHIP INDICATORS
1. Details of a business process being modified / introduced as a result of addressing human rights grievances/complaints.
Not applicable. During the FY, the Company did not receive any grievances or complaints related to human rights principles and
guidelines. As a result, there have been no modifications or introductions of new business processes specifically in response to such
issues. The current processes and policies, including the Whistle Blower Policy and grievance redressal mechanisms, remain effective in
maintaining and upholding human rights standards across the operations.
2. Details of the scope and coverage of any Human rights due-diligence conducted.
The Company’s approach to human rights due diligence is embedded within its Code of Conduct, which all employees are required
to adhere to. This Code addresses several human rights issues, including anti-bribery and anti-corruption measures. As part of the due
diligence process, it assess potential impacts on human rights before initiating new activities or business relationships and when there
are operational changes.
It also conducts thorough evaluations to identify and mitigate any adverse effects the activities might have on human rights. This
includes implementing appropriate prevention measures and regularly monitoring their effectiveness. This proactive approach
ensures that the Company addresses any human rights concerns before they arise, aligning the operations with its commitment to
uphold high standards of ethical conduct and respect for human rights.
3. Is the premise/office of the entity accessible to differently abled visitors, as per the requirements of the Rights of Persons
with Disabilities Act, 2016?
Yes, the Company is committed to promoting equal opportunities and ensuring an inclusive environment for all individuals. The registered
and corporate offices are situated in commercial premises that are equipped with ramps, elevators, and other accessibility features, in
accordance with the requirements of the Rights of Persons with Disabilities Act, 2016. These provisions ensure that visitors with disabilities
have full and equal access to the facilities, reflecting the Company’s dedication to fostering a diverse and equitable workplace.
4. Details on assessment of value chain partners:

% of value chain partners (by value of business


done with such partners) that were assessed
Sexual Harassment Refer Note Below
Discrimination at workplace Refer Note Below
Child Labour Refer Note Below
Forced Labour/Involuntary Labour Refer Note Below
Wages Refer Note Below
Others – please specify -
In line with the Company’s policy, it has identified primary vendors who provide more than 50% of the raw materials for a specific
product. It conduct thorough evaluations for each of these critical vendors, addressing aspects such as environmental impact, health
and safety standards, labor practices, data privacy, and crisis management.
5. Provide details of any corrective actions taken or underway to address significant risks / concerns arising from the
assessments at Question 4 above.
No significant risks or concerns were identified in the assessment during the FY.

94
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

PRINCIPLE 6 Businesses should respect and make efforts to protect and restore the environment

ESSENTIAL INDICATORS
1. Details of total energy consumption (in Joules or multiples) and energy intensity, in the following format:

Parameter FY 2023-24 FY 2022-23


(Current Financial Year) (Previous Financial Year)
From renewable sources
Total electricity consumption (A) 2758 4245
- Gigajoules
Total fuel consumption (B) 0 0
- Gigajoules
Energy consumption through other sources (C) 0 0
Total energy consumed from renewable sources (A+B+C) 2758 4245
- Gigajoules
From non-renewable sources
Total Electricity Consumption (D) 56,323 59,154
- Gigajoules
Total Fuel Consumption (E) 321,253 873,201
- Gigajoules
Energy consumption through other sources (F) 0 0
Total energy consumed from non-renewable sources (D+E+F) 377,576 932,354
- Gigajoules
Total energy consumed (A+B+C+D+E+F) 380,334 936,600
- Gigajoules
Energy intensity per rupee of turnover 0.000078890 0.000144674
- Gigajoules per Rupee of Turnover adjusted for PPP
(Total energy consumed / Revenue from operations)
Energy intensity per rupee of turnover adjusted for Purchasing 0.001595162 0.002925311
Power Parity (PPP)*
- Gigajoules per Metric Tonne (MT) of Physical Output
(Total energy consumed / Revenue from operations adjusted for PPP)
Energy intensity in terms of physical 173.5890091 335.4583733
Output
- Gigajoules per Metric Tonne (MT) of Physical Output
Energy intensity (optional) – the relevant metric may be selected by - -
the entity
A few units at the Tarapur location were shut down due to decreased demand for one of the products, resulting in lower energy
consumption during FY 23-24.
*The revenue from operations has been adjusted using the most recent PPP conversion factor for India published by the World Bank
in 2022, which is 20.22.
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, name
of the external agency.
During the FY, the Company has not undertaken any independent assessment/evaluation/assurance of the data disclosed.
2. Does the entity have any sites / facilities identified as designated consumers (DCs) under the Performance, Achieve and
Trade (PAT) Scheme of the Government of India? (Y/N) If yes, disclose whether targets set under the PAT scheme have
been achieved. In case targets have not been achieved, provide the remedial action taken, if any.
No, the Company is not identified as a designated consumer (DC) under the Performance, Achieve and Trade (PAT) Scheme of the
Government of India. Therefore, the targets set under the PAT scheme do not apply to the business.

95
Bajaj Healthcare Limited

3. Provide details of the following disclosures related to water, in the following format:

Parameter FY 2023-24 FY 2022-23


(Current Financial Year) (Previous Financial Year)
Water withdrawal by source (in kilolitres)
(i) Surface water - 103857
- Kilolitres
(ii) Groundwater 57986 36860
- Kilolitres
(iii) Third party water 115909 95665
- Kilolitres
(iv) Seawater / desalinated water 0 0
(v) Others 0 0
Total volume of water withdrawal (I + ii + iii + iv + v) 173895 236382
- Kilolitres
Total volume of water consumption 173895 236382
- Kilolitres
Water intensity per rupee of turnover (Total Water 0.000036070 0.000036513
Consumption / Revenue from operations) - Kilolitres per Rupee
of Turnover
Water intensity per rupee of turnover adjusted for 0.000729336 0.000738299
Purchasing Power Parity (PPP)*
(Total water consumption / Revenue from operations adjusted
for PPP) - Kilolitres per Rupee of Turnover adjusted for PPP
Water intensity in terms of physical output 79.36787768 84.66404011
- Kilolitres per Metric Tonne (MT) of physical output
Water intensity (optional) – the relevant metric may be - -
selected by the entity
A few units at the Tarapur location were shut down due to decreased demand for one of the products, resulting in lower water
consumption during FY 23-24.
*The revenue from operations has been adjusted using the most recent PPP conversion factor for India published by the World Bank
in 2022, which is 20.22.
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, name
of the external agency.
During the FY, the Company has not undertaken any independent assessment/evaluation/assurance of the data disclosed.
4. Provide the following details related to water discharged:

Parameter FY 2023-24 FY 2022-23


(Current Financial Year) (Previous Financial Year)
Water discharge by destination and level of treatment (in kilolitres)*
(i) To Surface water
- No treatment - -
- With treatment – please specify level of treatment - -
(ii) To Groundwater
- No treatment - -
- With treatment – please specify level of treatment - -
(iii) To Seawater
- No treatment - -
- With treatment – please specify level of treatment - -
(iv) Sent to third-parties
- No treatment - -
- With treatment – please specify level of treatment - -
(v) Others
- No treatment - -
- With treatment – please specify level of treatment - -
Total water discharged - -

96
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

The Company has implemented advanced water management practices across its operations. One of its units operates as a Zero
Liquid Discharge (ZLD) facility, ensuring that all wastewater is effectively treated and reused within the unit. For the remaining units,
Effluent Treatment Plants are in place, where wastewater is either recycled and reused or sent to a third party for treatment. The
Company is dedicated to maintaining detailed quantitative data on water discharge and will ensure comprehensive and transparent
reporting in the coming years.
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, name
of the external agency.
During the FY, the Company has not undertaken any independent assessment/evaluation/assurance of the data disclosed.
5. Has the entity implemented a mechanism for Zero Liquid Discharge? If yes, provide details of its coverage and
implementation.
Yes, the Company has implemented a comprehensive mechanism at several manufacturing sites to address wastewater management.
At these locations, it has established advanced effluent treatment plants (ETPs) that are specifically designed to treat the wastewater
generated during production processes. The treated water undergoes a stringent purification process, ensuring that it meets the
required standards for safe reuse within the facility. This treated water is then repurposed for various ancillary operations, including
site gardening, cooling towers, and other non-potable uses, significantly reducing our reliance on fresh water and minimizing our
environmental footprint.
A notable example is the Panoli unit, which operates as a full ZLD facility. At this site, no liquid waste is discharged into the environment,
aligning with the commitment to sustainable and responsible manufacturing practices. In addition, the Company is actively exploring
and implementing enhancements to the ETP capabilities at other units with the goal of achieving ZLD status across more of the
locations. This initiative is part of the broader environmental sustainability strategy, which seeks to minimize waste, conserve resources,
and reduce the overall environmental impact.
6. Please provide details of air emissions (other than GHG emissions) by the entity, in the following format:

Parameter Please FY 2023-24 FY2022-23


specify unit (Current Financial Year) (Previous Financial Year)
Nox ug/m3 46.36 48.57
Sox ug/m3 32.68 33.9
Particulate matter (PM) mg/m3 87.43 203.7
Persistent organic pollutants (POP) - -
Volatile organic compounds (VOC) - -
Hazardous air pollutants (HAP) - -
Others – please specify - -
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, name
of the external agency.
The Company has five manufacturing plants, each of which has conducted air quality tests with different external agencies throughout
the year. This makes it difficult to specify all the agency details here.
7. Provide details of greenhouse gas emissions (Scope 1 and Scope 2 emissions) & its intensity, in the following format:

Parameter Unit FY 2023-24 FY 2022-23


(Current Financial Year) (Previous Financial Year)
Total Scope 1 emissions Metric tonnes of 32,208 87,660
(Break-up of the GHG into CO2, CH4, N2O, HFCs, PFCs, CO2 equivalent
SF6, NF3, if available)

Total Scope 2 emissions Metric tonnes of 11,202 11,765


- in Metric Tonnes CO2 equivalent

Total Scope 1 and Scope 2 emission intensity per - 0.000009004 0.000015358


rupee of turnover
(Total Scope 1 and Scope 2 GHG emissions / Revenue
from operations) - per Rupee of Turnover

97
Bajaj Healthcare Limited

Parameter Unit FY 2023-24 FY 2022-23


(Current Financial Year) (Previous Financial Year)

Total Scope 1 and Scope 2 emission intensity per - 0.000182067 0.000310536


rupee of turnover adjusted for Purchasing Power
Parity (PPP)*
(Total Scope 1 and Scope 2 GHG emissions / Revenue
from operations adjusted for PPP) - per Rupee of
Turnover adjusted for PPP

Total Scope 1 and Scope 2 emission intensity in - 19.81292527 35.61056473


terms of physical output
- per Metric Tonne (MT) of Physical Output

Total Scope 1 and Scope 2 emission intensity - - -


(optional) – the relevant metric may be selected by the
entity

A few units in tarapur location were shut down due to decreased demand for one of the products, resulting in lower Emissions during
FY 23-24
*The revenue from operations has been adjusted using the most recent PPP conversion factor for India published by the World Bank
in 2022, which is 20.22.
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, name
of the external agency.
During the FY, the Company has not undertaken any independent assessment/evaluation/assurance of the data disclosed.
8. Does the entity have any project related to reducing Green House Gas emission? If Yes, then provide details.
Yes, the Company has undertaken several projects aimed at reducing Greenhouse Gas (GHG) emissions across the operations. It has
implemented a multi-faceted approach that includes both technological upgrades and sustainability initiatives to minimize the carbon
footprint.
1. Installation of Solar Panels: It has installed solar panels with significant capacity on vacant land within the factory premises.
These panels harness renewable energy, contributing to a reduction in reliance on conventional power sources and lowering the
overall GHG emissions.
2. Improvement of Thermal Efficiency: To prevent heat loss and enhance energy efficiency, it has replaced old insulation on
reactors and the cold well of the brine storage tank. This initiative has improved the thermal performance of the processes,
leading to reduced energy consumption and lower GHG emissions.
3. Transition to LED Lighting: In the ongoing efforts to conserve energy and reduce carbon emissions, it has replaced mercury
vapor lamps with energy-efficient LED lamps across the operations. LED lights are not only more efficient but also have a longer
lifespan, which reduces both energy consumption and waste.
4. Indoor Plantation: It actively promotes greenery by planting indoor plants in the offices and surrounding areas. This initiative
not only enhances the aesthetic appeal of the work environment but also improves air quality, contributing to a healthier and
more sustainable workplace. Indoor plants help in absorbing carbon dioxide and releasing oxygen, thereby reducing the overall
carbon footprint.
5. Energy Optimization Measures: Beyond specific projects, it has taken a broader approach to energy optimization. This
includes replacing low energy-efficient equipment with high-efficiency alternatives, optimizing energy consumption in the office
buildings, and adopting digitization. These measures collectively contribute to reducing the energy demand and associated GHG
emissions.
6. Awareness and Behavioral Change: It recognizes the importance of creating a culture of sustainability among the workforce.
To this end, it has fostered awareness about energy conservation and GHG reduction initiatives through training programs,
workshops, and internal communications. Encouraging workforce to adopt energy-saving practices in their daily routines is a
critical component of Company’s strategy to reduce the environmental impact.
These efforts reflect the commitment to sustainability and the proactive approach to mitigating climate change by reducing
greenhouse gas emissions across the operations.

98
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

9. Provide details related to waste management by the entity, in the following format:

Parameter FY 2023-24 FY 2022-23


(Current Financial Year) (Previous Financial Year)
Total Waste generated (in metric tonnes)
Plastic waste (A) 11.154 26.57
E-waste (B) - 0.0327
Bio-medical waste C) - 0
Construction and demolition waste (D) - 60.7
Battery waste (E) - 0
Radioactive waste (F) - 0
Hazardous waste (G) 1425.416 2267.195
Other Waste: other non-hazardous waste (H) - 540
Total (A+B + C + D + E + F + G + H)* - Metric Tonne (MT) 1437 2894
Waste intensity per rupee of turnover 0.000000298 0.000000447
(Total waste generated / Revenue from operations)
- Metric Tonne (MT) per Rupee of Turnover
Waste intensity per rupee of turnover adjusted for Purchasing 0.000006025 0.000009040
Power Parity (PPP)**
(Total waste generated / Revenue from operations adjusted for PPP)
- Metric Tonne (MT) per Rupee of Turnover adjusted for PPP
Waste intensity in terms of physical output - Metric Tonne (MT) 0.655668644 1.036711211
per Metric Tonne (MT) of Physical Output
Waste intensity (optional) – the relevant metric may be selected - -
by the entity
For each category of waste generated, total waste recovered through recycling, re-using or other recovery operations
(in metric tonnes)
*Category of waste
(i) Recycled 11.154 26.57
(ii) Re-used 0 0
(iii) Other recovery operations 0 0
Total 11.154 26.57
For each category of waste generated, total waste disposed by nature of disposal method (in metric tonnes)
*Category of waste
(i) Incineration 685.115 1530.495
(ii) Landfilling 740.125 736.7
(iii) Other disposal operations - 0
Total 1425.24 2293.765

A few units at the Tarapur location were shut down due to decreased demand for one of the products, resulting in lower waste
generation during FY 23-24.
*Plastic waste and hazardous waste are managed as follows: plastic waste is sent to authorized dealers for recycling, hazardous waste
is handled through incineration or co-processing, and landfilling.
**The revenue from operations has been adjusted using the most recent PPP conversion factor for India published by the World Bank
in 2022, which is 20.22.
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, name
of the external agency.
During the FY, the Company has not undertaken any independent assessment/evaluation/assurance of the data disclosed

99
Bajaj Healthcare Limited

10. Briefly describe the waste management practices adopted in your establishments. Describe the strategy adopted by your
Company to reduce usage of hazardous and toxic chemicals in your products and processes and the practices adopted to
manage such wastes.
The Company prioritizes environmentally sound waste management practices and have developed a comprehensive strategy to
minimize waste generation and ensure responsible disposal across all the operations.
Waste Management Practices
1. Elimination of Hazardous Waste Landfilling:
• It has achieved a significant milestone by completely eliminating the practice of landfilling hazardous waste from the
operations. This means that all hazardous waste is managed through alternative methods to minimize environmental impact.
2. Recycling and Disposal of Non-Hazardous Waste:
• It has established systematic procedures for handling non-hazardous waste, including plastics, e-waste, and general
waste. Plastic waste generated from the operations is collected and sent to authorize scrap dealers who process it in
an environmentally responsible manner. For electronic waste, it strictly adheres to regulatory requirements by ensuring
it is collected and disposed of through authorized scrap collectors and vendors. Additionally, other non-hazardous
materials such as paper, wood, glass, and metal are sorted and sent for recycling, thus reducing landfill usage and
promoting material reuse.
3. Management of Hazardous Waste:
• Hazardous waste, including chemical by-products and residues, is managed with the utmost care. It is collected and
transported to authorized third-party recyclers or co-processors who ensure that the waste is processed in compliance with
hazardous waste management regulations.
• It continually review and update the hazardous waste management procedures to align with best practices and regulatory
requirements.
4. Water Recycling and Reuse:
• As part of the waste management strategy, it has implemented systems for recycling and reusing water within the facilities.
This not only conserves water but also reduces the volume of wastewater that needs treatment.
5. Training and Awareness Programs:
• It conducts regular training and awareness programs for the employees and workers on waste minimization and
management techniques. This includes educating staff on best practices for reducing waste generation at the source
and providing emergency response training to ensure safe handling and storage of waste materials. Additionally, it offers
instruction on proper waste segregation, storage, and disposal methods to ensure compliance with environmental
regulations.
The Company continually assess and improve the waste management practices to enhance their effectiveness and ensure
compliance with evolving regulations. This commitment to continuous improvement reflects the broader environmental
responsibility and dedication to minimizing the ecological footprint. Through these comprehensive measures, it strives to
uphold the highest standards of environmental stewardship and sustainability.
11. If the entity has operations/offices in/around ecologically sensitive areas (such as national parks, wildlife sanctuaries,
biosphere reserves, wetlands, biodiversity hotspots, forests, coastal regulation zones etc.) where environmental
approvals / clearances are required, please specify details in the following format:

S. No. Location of Type of Whether the conditions of environmental approval / clearance are being
operations/ operations complied with? (Y/N)
offices
If no, the reasons thereof and corrective action taken, if any.

Nil Nil Nil Nil

12. Details of environmental impact assessments of projects undertaken by the entity based on applicable laws, in the
current financial year:

Name and brief EIA Notification Date Whether conducted by independent Results communicated in Relevant
details of project No. external agency (Yes / No) public domain (Yes / No) Web link

Nil Nil Nil Nil Nil Nil

100
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

13. Is the entity compliant with the applicable environmental law/ regulations/ guidelines in India; such as the Water
(Prevention and Control of Pollution) Act, Air (Prevention and Control of Pollution) Act, and Environment protection act
and rules thereunder (Y/N). If not, provide details of all such non-compliances, in the following format:

S. No. Specify the law / regulation Provide details of the Any fines / penalties / action taken by Corrective
/ guidelines which was not non-compliance regulatory agencies such as pollution action
complied with control boards or by courts taken, if any
Nil Nil Nil Nil Nil

LEADERSHIP INDICATORS
1. Water withdrawal, consumption and discharge in areas of water stress (in kilolitres):
For each facility / plant located in areas of water stress, provide the following information:
(i) Name of the area –
(ii) Nature of operations –
(iii) Water withdrawal, consumption and discharge in the following format:
None of the manufacturing facilities/offices of the Company fall in/around water stress areas.

Parameter FY 2023-24 FY 2022-23


(Current Financial Year) (Previous Financial Year)
Water withdrawal by source (in kilolitres)
(i) Surface water Nil Nil
(ii) Groundwater Nil Nil
(iii) Third party water Nil Nil
(iv) Seawater / desalinated water Nil Nil
(v) Others Nil Nil
Total volume of water withdrawal (in kilolitres) Nil Nil
Total volume of water consumption (in kilolitres) Nil Nil
Water intensity per rupee of turnover (Water consumed / - -
turnover)
Water intensity (optional) – the relevant metric may be - -
selected by the entity
Water discharge by destination and level of treatment (in kilolitres)
(i) Into Surface water Not Applicable Not Applicable
- No treatment - -
- With treatment – please specify level of treatment - -
(ii) Into Groundwater Not Applicable Not Applicable
- No treatment - -
- With treatment – please specify level of treatment - -
(iii) Into Seawater Not Applicable Not Applicable
- No treatment - -
- With treatment – please specify level of treatment - -
(iv) Sent to third-parties Not Applicable Not Applicable
- No treatment - -
-With treatment – please specify level of treatment - -
(v) Others Not Applicable Not Applicable
- No treatment - -
- With treatment – please specify level of treatment - -
Total water discharged (in kilolitres) Nil Nil
Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes,
name of the external agency.
Not Applicable

101
Bajaj Healthcare Limited

2. Please provide details of total Scope 3 emissions & its intensity, in the following format:

Parameter Unit FY 2023-24 FY 2022-23


(Current Financial Year) (Previous Financial Year)
Total Scope 3 emissions Metric tonnes of - -
CO2 equivalent
(Transport Facility given to Management
Personnels/Employees)
Total Scope 3 emissions per rupee of turnover - -
Total Scope 3 emission intensity (optional) – - -
the relevant metric may be selected by the entity

Note: Indicate if any independent assessment/ evaluation/assurance has been carried out by an external agency? (Y/N) If yes, name
of the external agency.
Not Applicable
3. With respect to the ecologically sensitive areas reported at Question 10 of Essential Indicators above, provide details of
significant direct & indirect impact of the entity on biodiversity in such areas along-with prevention and remediation
activities.
Not Applicable
4. If the entity has undertaken any specific initiatives or used innovative technology or solutions to improve resource
efficiency, or reduce impact due to emissions / effluent discharge / waste generated, please provide details of the same
as well as outcome of such initiatives, as per the following format:

Sr. No Initiative undertaken Details of the initiative (Web-link, if any, Outcome of the initiative
may be provided along-with summary)

Nil Nil Nil Nil

5. Does the entity have a business continuity and disaster management plan? Give details in 100 words/ web link.
Yes, the Company has a comprehensive Business Continuity and Disaster Management Plan in place. The on-site emergency plan
is meticulously designed to manage various types of incidents efficiently. In the event of an emergency, employees or workers are
trained to alert those nearby by shouting “Emergency” and triggering the alarm system, which can be activated either automatically or
manually. Once an incident is detected, security personnel are informed of the location, type of emergency, and any injuries.
The Security Officer promptly communicates with the Site Controller and Incident Controller, who then coordinate the emergency
response. The Site Controller rushes to the Emergency Control Center to oversee the situation and direct the Incident Controller and
Security staff. Depending on the severity of the emergency, the Site Controller may order an evacuation.
Teams responsible for Evacuation, Fire Fighting, and First Aid act under the direction of the Incident Controller, who provides updates and
instructions throughout the emergency. All personnel are trained to evacuate calmly to designated assembly points, where a headcount
is conducted. Special assistance is provided to pregnant or lactating women, disabled individuals, or those with other special needs.
The plan also includes specific protocols for various emergencies, such as handling burns, scalds, fractures, electrical shocks, chemical
spills, food poisoning, and natural calamities. Measures are taken to contain and manage chemical leaks, structural collapses, and
environmental emergencies, with clear steps for evacuation, containment, and medical assistance.
6. Disclose any significant adverse impact to the environment, arising from the value chain of the entity. What mitigation or
adaptation measures have been taken by the entity in this regard?
No significant adverse impacts to the environment arising from the value chain have been reported or informed to the Company. The
Company is committed to environmental stewardship and proactively manage its operations to minimize any potential environmental
impacts. The comprehensive environmental management practices include stringent waste management protocols, resource
optimization, and pollution control measures. It continuously monitor the environmental performance and engage with the value
chain partners to ensure adherence to environmental standards and best practices. In the unlikely event that an environmental issue
arises, it is prepared to implement appropriate mitigation and adaptation measures to address and rectify the situation promptly.
7. Percentage of value chain partners (by value of business done with such partners) that were assessed for environmental impacts.
In line with the Company’s policy, it has identified primary vendors who provide more than 50% of the raw materials for a specific
product. It conduct thorough evaluations for each of these critical vendors, addressing aspects such as environmental impact, health
and safety standards, labor practices, data privacy, and crisis management.

102
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

PRINCIPLE 7 Businesses, when engaging in influencing public and regulatory policy, should do so in a manner that is
responsible and transparent

ESSENTIAL INDICATORS
1. a. Number of affiliations with trade and industry chambers/ associations.
The Company is member of 4 (Four) trade and industry chambers/ associations.
b. List the top 10 trade and industry chambers/ associations (determined based on the total members of such body)
the entity is a member of/ affiliated to.

S. No. Name of the trade and industry chambers/ associations Reach of trade and industry chambers/
associations (State/National)
1 Confederation of Indian Industry (CII) National
2 The Associated Chambers of Commerce and Industry (ASSOCHAM) National
3 Pharmaceutical Export Promotion Council of India (PHARMEXCIL) National
4 Federation of Pharmaceutical and Allied Products Merchant Exporters (FPME) National

2. Provide details of corrective action taken or underway on any issues related to anti-competitive conduct by the entity,
based on adverse orders from regulatory authorities.

Name of authority Brief of the case Corrective action taken


Nil Nil Nil

There were no such matter related to anti-competitive conduct by the entity were reported during the FY.

LEADERSHIP INDICATORS
1. Details of public policy positions advocated by the entity:

S. No. Public policy Method Whether information Frequency of Review by Board Web Link, if
advocated resorted for available in public (Annually/ Half yearly/ Quarterly available
such advocacy domain? (Yes/No) / Others – please specify)

Nil Nil Nil Nil Nil Nil

PRINCIPLE 8 Businesses should promote inclusive growth and equitable development

ESSENTIAL INDICATORS
1. Details of Social Impact Assessments (SIA) of projects undertaken by the entity based on applicable laws, in the current
financial year.

Name and brief SIA Notification Date of Whether conducted by Results communicated Relevant
details of project No. notification independent external agency in public domain Web link
(Yes / No) (Yes / No)

Nil Nil Nil Nil Nil Nil

During the FY, the Company did not undertake any projects that required a Social Impact Assessment (SIA) according to applicable
laws. As a result, there were no SIAs conducted or documented for this period.
2. Provide information on project(s) for which ongoing Rehabilitation and Resettlement (R&R) is being undertaken by your
entity, in the following format:

S. No. Name of Project for State District No. of Project Affected % of PAFs Amounts paid to PAFs
which R&R is ongoing Families (PAFs) covered by R&R in the FY (In INR)
Nil Nil Nil Nil Nil Nil Nil

During the FY, the Company has not undertaken any projects that required Rehabilitation and Resettlement (R&R) of local communities.
As a result, there are no relevant web links or information pertaining to ongoing R&R projects.

103
Bajaj Healthcare Limited

3. Describe the mechanisms to receive and redress grievances of the community.


The Company has established effective mechanisms to receive and address grievances from the community. As part of its commitment
to social responsibility, its implements various CSR projects focused on health and wellness, education, skill development, women’s
empowerment, hygiene and sanitation, and environmental sustainability, including biodiversity, energy, and water conservation.
To facilitate the redressal of community grievances, the Company maintains a register during visits to peripheral areas of its operating
locations. This register is accessible to all community members, providing a platform for them to raise any concerns or submit
written complaints. These issues are promptly reviewed and addressed by the appropriate authorities, fostering a culture of trust and
collaboration.
Furthermore, the CSR initiatives are managed by a dedicated committee that actively engages with the community. The Company
encourages feedback both in person and through its website’s “Contact Us” page at https://www.bajajhealth.com/contact/. This
ensures that community concerns are heard and acted upon effectively.
4. Percentage of input material (inputs to total inputs by value) sourced from suppliers:

FY 2023-24 (Current Financial Year) FY 2022-23 (Previous Financial


Year)
Directly sourced from MSMEs/ small producers 5% 5%
Directly from within India 74% 47%
5. Job creation in smaller towns – Disclose wages paid to persons employed (including employees or workers employed on
a permanent or non-permanent / on contract basis) in the following locations, as % of total wage cost:

Location FY 2023-24 (Current Financial Year) FY 2022-23 (Previous Financial


Year)
Rural 28% 25%
Semi – urban 23% 26%
Urban 49% 49%
Metropolitan 0% 0%

LEADERSHIP INDICATORS
1. Provide details of actions taken to mitigate any negative social impacts identified in the Social Impact Assessments
(Reference: Question 1 of Essential Indicators above):

Details of negative social impact identified Corrective action taken


Not Applicable Not Applicable
2. Provide the following information on CSR projects undertaken by your entity in designated aspirational districts as
identified by government bodies:

S. No. State Aspirational District Amount spent (In INR)


Nil Nil Nil Nil
3. (a) Do you have a preferential procurement policy where you give preference to purchase from suppliers comprising
marginalized /vulnerable groups? (Yes/No)
(b) From which marginalized /vulnerable groups do you procure?
(c) What percentage of total procurement (by value) does it constitute?
No, the Company does not have a preferential procurement policy that gives preference to suppliers from marginalized or
vulnerable groups. It adheres to its standard Code of Conduct for all suppliers and partners. This approach ensures that all
procurement decisions are made based on quality, value, and compliance with our established standards, rather than specific
preferences for supplier demographics. Consequently, there is no procurement percentage from marginalized or vulnerable
groups to report.
4. Details of the benefits derived and shared from the intellectual properties owned or acquired by your entity (in the
current financial year), based on traditional knowledge:

104
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

S. No. Intellectual Property based Owned/ Acquired (Yes/No) Benefit shared Basis of calculating
on traditional knowledge (Yes / No) benefit share
Nil Nil Nil Nil Nil
5. Details of corrective actions taken or underway, based on any adverse order in intellectual property related disputes
wherein usage of traditional knowledge is involved.

Name of authority Brief of the Case Corrective action taken


Not Applicable Not Applicable Not Applicable
6. Details of beneficiaries of CSR Projects:

S. No. CSR Project No. of persons benefitted from % of beneficiaries from vulnerable and
CSR Projects marginalized groups
1 Support towards healthcare Refer Note Refer Note
Due to the nature of CSR projects, precisely quantifying the exact number of beneficiaries can be challenging. However, the Company
has ensured that these projects are tailored to support marginalized and vulnerable groups, addressing their specific needs and
enhancing their well-being.
PRINCIPLE 9 Businesses should engage with and provide value to their consumers in a responsible manner

ESSENTIAL INDICATORS
1. Describe the mechanisms in place to receive and respond to consumer complaints and feedback.
The Company has established comprehensive mechanisms to effectively receive and address consumer complaints and feedback.
Customers can submit their complaints or provide feedback through various channels. The Company’s website features a dedicated
‘Contact Us’ section, which includes an ‘Enquiry Form’ that allows customers to detail their product-related issues. This form is accessible
at https://www.bajajhealth.com/contact/. In addition to the online form, customers can also communicate via email or courier to
register their concerns.
All submissions are systematically tracked and monitored by the Company to ensure that each complaint or piece of feedback is
addressed promptly. The Company maintains a rigorous process for reviewing and analyzing customer inputs to identify any recurring
issues or areas for improvement. Based on the feedback received, corrective measures are planned and implemented to resolve
complaints and enhance its offerings.
The Company is committed to taking all customer feedback seriously. It actively uses this feedback to refine its action plans and
improve the products and services. The goal is to continuously update Company’s performance and uphold the highest standards of
quality. Through these mechanisms, it strives to provide exceptional products and services and maintain a strong relationship with its
customers.
2. Turnover of products and/ services as a percentage of turnover from all products/service that carry information about:

As a Percentage of total Turnover


Environmental and social parameters Not applicable – The pharmaceutical products are prescribed by physicians and do not
relevant to the product have specific environmental and social parameters associated with them.
Safe and responsible usage The pharmaceutical medicines and drugs include essential information on their
packaging, such as guidance on storage conditions, handling, dosage, and expiry dates,
to ensure safe and effective use.
Recycling and/or safe disposal Not applicable – Although the products do not specifically display additional details beyond
statutory requirements, the Company adheres to all relevant regulations, including those set
by Pollution Control Boards and Extended Producer Responsibility guidelines.

3. Number of consumer complaints in respect of the following:

105
Bajaj Healthcare Limited

FY 2023-24 Remarks FY 2022-23 Remarks


(Current Financial Year) (Previous Financial Year)
Received Pending Received Pending
during resolution at during resolution at
the year end of year the year end of year
Data privacy Nil Nil Not Applicable Nil Nil Not Applicable
Advertising Nil Nil Not Applicable Nil Nil Not Applicable
Cyber-security Nil Nil Not Applicable Nil Nil Not Applicable
Delivery of essential services Nil Nil Not Applicable Nil Nil Not Applicable
Restrictive Trade Practices Nil Nil Not Applicable Nil Nil Not Applicable
Unfair Trade Practices Nil Nil Not Applicable Nil Nil Not Applicable
Other Nil Nil Not Applicable Nil Nil Not Applicable
4. Details of instances of product recalls on account of safety issues:

Number Reasons for recall


Voluntary recalls Nil Not Applicable
Forced recalls Nil Not Applicable
5. Does the entity have a framework/ policy on cyber security and risks related to data privacy? (Yes/No) If available, provide
a web-link of the policy.
Yes, the Company has established a robust Risk Management Policy that comprehensively covers cyber security and data privacy risks.
This policy is designed to address a wide range of potential threats and vulnerabilities related to cyber security and ensures that the
Company has appropriate measures in place to protect sensitive data and maintain the integrity of its operations.
The Risk Management Policy includes detailed protocols for identifying, assessing, and managing cyber security risks, as well as
procedures for safeguarding data privacy. It outlines the Company’s approach to mitigating risks associated with unauthorized access,
data breaches, and other cyber threats. Additionally, the policy establishes guidelines for responding to and recovering from cyber
incidents to minimize their impact on the Company.
The Company is committed to continuously improving its cyber security posture and adapting its strategies to evolving threats and
regulatory requirements. This proactive approach helps to ensure that the operations remain secure and that it upholds the highest
standards of data privacy.
For further details, the Risk Management Policy is available at https://www.bajajhealth.com/wp-content/uploads/2023/05/Risk-
Management-Policy-1.pdf
6. Provide details of any corrective actions taken or underway on issues relating to advertising, and delivery of essential
services; cyber security and data privacy of customers; re-occurrence of instances of product recalls; penalty / action
taken by regulatory authorities on safety of products / services.
There were no complaints or issues reported during the year related to advertising, delivery of essential services, cyber security, data
privacy of customers, re-occurrence of product recalls, or any penalties or actions taken by regulatory authorities regarding the safety
of our products and services. As a result, no corrective actions were required or undertaken in these areas. The Company remains
committed to maintaining the highest standards in all these aspects.
7. Provide the following information relating to data breaches:
a. Number of instances of data breaches-
During the FY, there were no instances of data breaches. The Company has maintained strict data security measures to protect
sensitive information, ensuring that no unauthorized access, disclosure, or breaches occurred.
b. Percentage of data breaches involving personally identifiable information of customers
Not Applicable
c. Impact, if any, of the data breaches-
Not Applicable

LEADERSHIP INDICATORS

106
Annual Report
Corporate Overview Statutory Reports Financial Statements 2023-24

1. Channels / platforms where information on products and services of the entity can be accessed (provide web link, if
available).
Information on the Company’s products and services can be accessed through its website. Detailed descriptions and information
are available at http://www.bajajhealth.com/#products. This platform provides comprehensive insights into the Company’s offerings,
ensuring easy access for all.
2. Steps taken to inform and educate consumers about safe and responsible usage of products and/or services.
To ensure the safe and responsible usage of the pharmaceutical products, the Company takes several steps to inform and educate
consumers. All of the Company’s products include comprehensive information, such as guidelines on storage conditions, handling,
proper dosage, and expiration dates. This information is clearly labeled on the packaging to help consumers use the medicines and
drugs safely and effectively.
3. Mechanisms in place to inform consumers of any risk of disruption/discontinuation of essential services.
The Company has mechanisms in place to inform consumers of any risk of disruption or discontinuation of essential services. In
compliance with the guidelines set by the National Pharmaceutical Pricing Authority, it discloses the discontinuation of any scheduled
formulation by issuing a public notice to relevant stakeholders. Additionally, it promptly inform the appropriate Authority to ensure
transparency and minimize any potential impact on consumers.
4. Does the entity display product information on the product over and above what is mandated as per local laws? (Yes/No/
Not Applicable) If yes, provide details in brief. Did your entity carry out any survey with regard to consumer satisfaction
relating to the major products / services of the entity, significant locations of operation of the entity or the entity as a
whole? (Yes/No)
No, the Company does not display product information beyond what is mandated by local laws. However, we are committed to
understanding consumer satisfaction and regularly conduct surveys through feedback forms. These surveys help us gauge customer
satisfaction with our major products and services across significant locations of operation. The insights gathered from these surveys
are used to enhance our offerings and improve overall customer experience.

107

You might also like